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Carotenoid dietary intake and their endogenous levels have been associated with a decreased
risk of several chronic diseases. There are indications that carotenoid bioavailability depends,
in addition to the food matrix, on host factors. These include diseases (e.g. colitis), life-style
habits (e.g. smoking), gender and age, as well as genetic variations including single nucleotide
polymorphisms that govern carotenoid metabolism. These are expected to explain interindivid-
ual differences that contribute to carotenoid uptake, distribution, metabolism and excretion,
and therefore possibly also their association with disease risk. For instance, digestion enzymes
fostering micellization (PNLIP, CES), expression of uptake/efflux transporters (SR-BI, CD36,
NPC1L1), cleavage enzymes (BCO1/2), intracellular transporters (FABP2), secretion into chy-
lomicrons (APOB,MTTP), carotenoidmetabolism in the blood and liver (LPL, APOC/E, LDLR),
and distribution to target tissues such as adipose tissue or macula (GSTP1, StARD3) depend
on the activity of these proteins. In addition, human microbiota, e.g. via altering bile-acid
concentrations, may play a role in carotenoid bioavailability. In order to comprehend individ-
ual, variable responses to these compounds, an improved knowledge on intra-/interindividual
factors determining carotenoid bioavailability, including tissue distribution, is required. Here,
we highlight the current knowledge on factors that may explain such intra-/interindividual
differences.
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Abbreviations: ADME, absorption, distribution, metabolism and
excretion; AMD, age related macular degeneration; AMY1, sali-
vary amylase gene 1; ABCA1, ATP binding cassette subfam-
ily A, member 1; ABCG5/G8, ATP binding cassette subfam-
ily G, member 5/8; ADH7, Alcohol dehydrogenase 7; ALDH1,
aldehyde dehydrogenase 1; APOA, 1–4, apolipoprotein A, 1–
4; APOB/C2/E/48, apolipoprotein B/C2/E/48; AUC, area under
(plasma/serum concentration-time) curve; BCO1/2, -carotene
oxygenase 1/2; CD36, cluster of differentiation 36 molecule;
CES1/2, human carboxyl-esterase 1/2; CETP, cholesteryl es-
ter transfer protein; CLPS, colipase; COBLL1, cordon-bleu WH2
repeat protein like 1; 9CRA, 9-cis-retinoic acid; 9CDHRA, 9-
cis-13, 14-dihydro-retinoic acid; CRISPR/CAS9, clustered reg-
ularly interspaced short palindromic repeats/protein-9 nucle-
ase; CXCL8, C-X-C motif chemokine ligand 8; CYP26B1, cy-
tochrome P450 family 26 subfamily B member 1; CYP7A1,
bile acid synthetic enzyme; ELOVL2, elongation of very long
chain fatty acids like 2; GI, gastro-intestinal; GPS, protein path-
way suppressor; GSTP1, glutathione S-transferase pi 1; HNF4A,
hepatocyte nuclear factor 4, alpha; FABP2/I-FABP, fatty acid
binding protein, intestinal; FGF4/19, fibroblast growth factor
4/19; FOXO1, forkhead box O1; FXR, farnesoid X receptor; IL8,
interleukin 8; INSIG2, insulin induced gene 2; IRS1, insulin
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1 Introduction
Carotenoids are natural pigments with a C-30 or C-40
backbone. They can be produced by most plants, bacteria,
and fungi, but not by animals or humans, making diet their
sole source. Carotenoids have recently been investigated with
much interest, as their dietary intake and endogenous con-
centrations have been associatedwith a reduced risk of several
chronic diseases. For example, carotenoid intake has been
positively associated with a reduced risk of cancer [1], type 2
diabetes mellitus (T2D) [2], cardiovascular diseases [3], and
asthma [4], while plasma carotene concentration was shown
to be significantly associated with reduced total mortality [5].
In addition, some carotenoids, including -, -carotene and
-cryptoxanthin (Fig. 1), are vitamin A precursors, constitut-
ing the predominant source of vitamin A in most developing
countries (up to 90% [6]) as well as in Western countries es-
pecially with respect to vegetarians. Recently, it has also been
suggested that cis-carotenoids are even more beneficial for
the prevention of atherosclerosis and T2D than their all-trans
isomers [7,8]. Finally, it is now acknowledged that lutein and
zeaxanthin play a role in vision by improving contrast sensi-
tivity and visual acuity [9] and participate in the prevention of
age-related macular degeneration [10].
However, several intervention trials with carotenoid sup-
plements have not supported these beneficial associations,
or even found negative health effects [11, 12]. To explain this
discrepancy, it is hypothesized that the food matrix (miss-
receptor substrate 1; ISX, intestine specific homeobox; KD,
equilibrium dissociation constant; LCAT, lecithin-cholesterol acyl-
transferase; LDLR, low density lipoprotein receptor; LIPC, li-
pase C, hepatic type; LIPF, gastric lipase; LPL, lipoprotein li-
pase; LRAT, lecithin-retinol acyltransferase; LRP1, low den-
sity lipoprotein receptor-related protein 1; LXR, liver X re-
ceptor; MC4R, melanocortin 4 receptor; MTTP/MTP, microso-
mal triglyceride transfer protein/gene; NF-B, nuclear factor
kappa-B; NRF2/NFE2L2, nuclear factor (erythroid-derived 2) like
2; NPC1L1, NPC1 like intracellular cholesterol transporter 1;
PGA3/4/5, pepsinogen3/4/5; PGC, progastricsin; PGC1, per-
oxisome proliferator-activated receptor gamma coactivator 1-
alpha; PKD1L2, polycystin 1 like 2; PLRP2, pancreatic lipase-
related protein-2; PNLIP, pancreatic lipase; PPAR, peroxisome
proliferator-activated receptor; PXR, pregnane X receptor; RAR,
retinoic acid receptor; RBP1/3/4, retinol binding protein 1/3/4;
RPE65, retinal pigment epithelium specific protein 65kDa; RSD,
relative standard deviation (RSD = SD/mean), equal to CV (co-
efficient of variation); RXR, retinoid X receptor; RXRA, retinoid
X receptor alpha; SAR1B, secretion associated Ras related GT-
Pase 1B; SR-BI/SCARB1, scavenger receptor class B member 1,
protein/gene; SHP, short heterodimer partner; SNP, single nu-
cleotide polymorphism; SETD7, SET domain containing lysine
methyltransferase 7; SLC27A6, solute carrier family 27 (fatty acid
transporter), member 6; SOD2, superoxide dismutase 2, mito-
chondrial; StARD3, StAR related lipid transfer domain containing
3; STRA6, stimulated by retinoic acid gene 6 protein homolog;
T2D, type II diabetes mellitus; TCF7L2, transcription factor 7 like
2; TRL, triacylglycerol-rich lipoprotein fraction;WT, wild-type
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Figure 1. Predominant carotenoids in our diet, commonmetabo-
lites and nomenclature.
ing synergistic effects, e.g. with other antioxidants such as
polyphenols), a larger array of natural occurring carotenoids
compared to single carotenoids in high amounts, presenta-
tion in the form of carotenoid supplements (powder, solid
matrix) and continuous intake in case of supplements, in-
fluence absorption, distribution, metabolism and excretion
(ADME), and therefore also their bioactivity. However, it has
also been emphasized that ADME-related factors, including
digestion andmatrix release, solubilisation inmixedmicelles,
epithelial uptake in the (small) intestine, and further bio-
distribution, all prerequisites for exerting potential biologi-
cal effects, can be different between individuals. This likely
results in variable blood/tissue concentrations [13–15]. How-
ever, blood plasma/serum alone may not constitute the best
indicator to assess carotenoid status, and additional methods,
such as isotopic labelling, similar as for retinoids [16] or easy
accessible compartments such as white blood cells [17] or
buccal cells [18], may allow for more insights regarding en-
dogenous carotenoid levels, carotenoid compartments, and
turnover [19].
This intra- and interindividual variability can be attributed,
in addition to dietary habits [20, 21], to host-related factors
(Table 1) including disease state [22–24], possibly physical
activity [25, 26], being overweight/obese [26], alcohol use
[25, 27, 28], smoking habits [26], drug intake [29], age [30],
and genetic aspects [31,32]. However, the underlying mecha-
nisms for this variability – e.g. lower bioaccessibility, reduced
C© 2017 The Authors. Molecular Nutrition & Food Research published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.mnf-journal.com
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Table 1. Overview of host (non-dietary) factors proposed to influence (in addition to genetic make-up and malabsorption diseases of the
GI) intra-and interindividual differences regarding carotenoid ADME
Factor Type of study Carotenoids investigated and variability Reference
Age Observational, n = 400 adults
(males, females)
Younger age correlated with lower serum
carotenoids
[164]
Observational, n = 946
postmenopausal women
Lower serum lycopene levels associated with
higher age
[30]
Observational, n = 12500 Lower serum -carotene levels with older age [272]
Review Higher plasma carotenoid levels with older
age
[273]
Alcohol Observational, n = 2895 women No consistent effect of alcohol consumption
on plasma levels of -carotene, -carotene,
-cryptoxanthin, and lutein-zeaxanthin
[26]
Observational, n = 194 men Negative correlations of plasma levels of
lycopene, -carotene, -cryptoxanthin (not
lutein) with units of alcohol/day, Spearman’s
rank correlation: -0.27 to -0.51
[25]
Observational, n = 1198
subjects
Higher alcohol consumption related to higher
plasma lycopene (ca. 20%), no effect on
-and -carotene, lutein, and
-cryptoxanthin
[28]
Intervention, n = 12 healthy
men
Consumption of wine, beer, or spirits for 3
weeks reduced plasma -carotene by 15%,
no effect on lycopene, lutein, zeaxanthin,
-cryptoxanthin, and -carotene
[27]
Observational, n = 400 adults
(male, female)
Higher alcohol consumption correlated with
lower serum carotenoids
[164]
Observational, n = 12500 adults
(male, female)
Lower -carotene levels with alcohol
consumption
[272]
Asthma Observational, women with
(n = 84) & without asthma
(n = 47)
Higher plasma total-carotenoids in women
with asthma
[253]
Body weight, BMI Observational, n = 2895 women Obese women had lower plasma levels of
-carotene, -carotene, -cryptoxanthin, and
lutein-zeaxanthin, by ca. 10%, compared to
normal-weight women. Plasma lycopene
was higher by 10%
[26]
Observational, n = 194 men Negative correlation of BMI with serum lutein
but not lycopene, -carotene,
-cryptoxanthin, R: -0.12 (Spearman rank
correlation)
[25]
Observational, n = 400 adults
(males, females)
Higher BMI associated with lower -and
-carotene and xanthophyll serum levels
[164]
Observational, n = 946
postmenopausal women
Higher BMI correlated with lower plasma
lycopene levels
[30]
Observational, n = 600 healthy
adults
Higher abdominal obesity related to lower
serum carotenoid levels (-,-carotene,
canthaxanthin
[274]
Observational, n = 55 women Similar total adipocyte -carotene content in
lean and obese, -carotene concentration
reduced in obese
[194]
Gender Observational, n = 12,500 adults
(male, female)
Women had higher serum -carotene levels
than men
[272]
Helicobacter pylori
infection
Observational, n = 49 anemic
patients (male, female)
Lower gastric mucosal -carotene reported
with increased H. pylori infection (though no
effect on plasma -carotene levels)
[22,275]
HIV Observational, n = 1669 women Lower serum -carotene levels in HIV subjects [276]
Hyperthyroidism Observational, n = 36 patients Lower serum -carotene in subjects with
hyperthyroidism compared to hypo-and
euthyroidism
[254]
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Table 1. Continued
Factor Type of study Carotenoids investigated and variability Reference
Low zinc status Intervention, n = 12 males Supplementation with zinc (20 mg/d)
improved plasma carotenoid concentration
[112]
Observational, n = 400 women
HIV positive
Lower serum -carotene associated with
markers of disease progression, univariate
regression, R: – 0.083-0.244
[24]
Observational, n = 1665 men
and women, healthy and
diabetic
20% lower plasma -carotene levels in
diabetes subjects compared to healthy ones
[277]
Blood lipids,
cholesterol
Observational, n = 400 adults
(male, female)
Higher non-HDL cholesterol associated with
lower serum carotenoids
[164]
Observational, n = 12,500
(male, female)
Higher total cholesterol and lower triglycerides
associated with higher -carotene in serum
[272]
Drug intake Intervention, n = 8 volunteers Intake of simvastatin (lipid-lowering drug), 40
mg/day for 8 weeks, reduced plasma levels
of carotenes (lycopene, -and -carotene)
and xanthophylls (-cryptoxanthin, lutein),
by 5 and 21%, respectively
[29]
Intervention trial, n = 6 patients
(1 male, 5 female)
Intake of orlistat (lipid-lowering drug)
decreased levels of -, and -carotene in
plasma
[278]
Intervention trial, n = 228 obese
subjects (male, female)
Intake of orlistat (lipid-lowering drug)
decreased -carotene levels in plasma
[279]
Malaria Observational, n = 100 malaria
and 50 control children (boys,
girls)
Lower serum concentration of all major
carotenoids compared to control
[280]
Menstrual cycle Intervention trial, n = 9 women Lower plasma carotenoids during early than
late follicular phase
[166]
Microbiota Observational, n = 25 subjects
(males, females)
Collinsella spp. were reduced in subjects with
atherosclerosis. These subjects had lower
-carotene in serum and the metagenome
showed lower phytoene-dehydrogenase.
[133]
Physical activity Observational, n = 2895 women Exercising women (>1 time/week) had higher
levels of -carotene, -carotene,
-cryptoxanthin, and lutein-zeaxanthin, by
ca. 5–10%, compared to normal-weight
individuals without exercise. No effect on
lycopene
[26]
Observational, n = 194 men Positive correlation of plasma levels of
-cryptoxanthin and lutein with physical
activity, rho: 0.12 to 0.17
[25]
Race/Ethnicity Observational, n = 4231
children and adolescents
(male, female)
African American children had higher
-cryptoxanthin, lutein, zeaxanthin, &
lycopene serum concentrations but lower
-carotene conc. than white children (not
adjusted for dietary intake)
[281]
Observational, n = 285 healthy
adolescents (male, female)
African-American participants had lower
serum concentrations of -carotene, but
higher conc. of lutein + zeaxanthin
compared with Caucasians (not adjusted for
dietary intake)
[282]
Smoking Observational, n = 194 men No relation of smoking to plasma levels of
lycopene, -carotene, -cryptoxanthin, lutein
[25]
Observational, n = 1198 adults
(male, female)
Increased smoking related to lower plasma
lycopene, - and -carotene, lutein,
-cryptoxanthin (ca. 10–30%), total
carotenoids ca. 50% lower
[283]
Observational, n = 400 adults
(male, female)
Smoking correlated with lower serum
carotenoids
[164]
Observational, n = 12,500 adults
(male, female)
Smoking correlated with lower -carotene
blood concentrations (not adjusted for
dietary intake)
[272]
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absorption, altered tissue distribution, turnover, and excre-
tion as well as possible interactions of individual carotenoids
on absorption and bio-activation of other carotenoids [33,34],
are only poorly understood. These factors can result in huge
variability of carotenoid absorption and circulating plasma
levels (Table 2). In a double tracer study [13] with D6
-carotene (37 mol), lowest AUC (area under the plasma-
concentration-time curve, mol h/L) versus highest AUC
were found to be 0.01 and 30.00, respectively. Major host
factors influencing carotenoid ADME patterns are likely to
include:
(i) Factors influencing carotenoid release from the food ma-
trix, and their transition from lipid droplets to mixed mi-
celles, i.e. factors impacting bioaccessibility. This includes
genes responsible for the expression of digestive enzymes
(e.g. gastric lipase, cholesterol esterase, pancreatic lipase,
etc.), and bile acid formation aiding in carotenoid micel-
lization [20, 35];
(ii) Factors altering carotenoid uptake into (or efflux out
of) the intestinal epithelium. This encompasses up-
take/efflux transporters such as scavenger receptor class
B member 1 (SR-BI), cluster of differentiation 36 (CD36),
and Niemann-Pick C1 like intracellular cholesterol trans-
porter 1 (NPC1L1), and perhaps other ATP-binding cas-
sette (ABC) proteins such as ABCG5/G8, or ABCA1
[31, 36], but also small intestinal surface available for ab-
sorption;
(iii) Factors contributing to intracellular cleavage, especially
BCO1/2 (-carotene oxygenase 1/2), responsible for cen-
tric/asymmetric cleavage of carotenoids, respectively, pro-
ducing a variety of retinoids and potential endogenous
occurring apocarotenoids [37–39];
(iv) Factors that impinge on carotenoid intracellular transport
in the gut epithelium, i.e. lecithin-retinol acyltransferase
(LRAT) for retinol (and perhaps other -carotene cleavage
products), and maybe intestinal fatty acid binding protein
(FABP2/I-FABP);
(v) Factors altering the secretion of carotenoid-containing
chylomicrons into the lymphatic system, such as
apolipoprotein B 48 (APOB48), APOAIV, SAR1B (secre-
tion associated Ras related GTPase1B), and microsomal
triglyceride transfer protein (MTTP) [38];
(vi) Factors influencing carotenoid transport in the blood
plasma/serum, such as their further distribution into
lipoproteins, e.g. lipoprotein lipase (LPL), APOA-I, APOB,
APOE and perhaps APOC3, and low density lipoprotein
receptor (LDLR) [40]; and the liver such as by hepatic li-
pase (LIPC);
(vii) Deposition of carotenoids in “target tissues”, e.g. the
macula (lutein, zeaxanthin), influenced by SR-BI, glu-
tathione S-transferase P1 isoform (GSTP1), StAR-related
lipid transfer domain protein 3 (StARD3), BCO1, choles-
terol transporters (SR-BI, ABCA1, ABCG5/8), retinal pig-
ment epithelial-specific protein (RPE65), elongation of
very long chain fatty acids like 2 (ELOVL2), and those
involved in visual pigment metabolism [41]. However,
also deposition in adipocytes, involving e.g. LDLR, could
play a role [42];
(viii) Any factor associated with carotenoid catabolism and ex-
cretion (in addition to BCO1/2), possibly those involv-
ing cytochrome P450 enzymes or the aryl-hydrocarbon-
receptor [43];
(ix) The microbiota. This may alter e.g. patterns and concen-
trations of secondary bile acids [44], or possibly carotenoid
absorption or degradation patterns [45], though it is not
sure if a significant fraction of carotenoids can be ab-
sorbed from the colon [46].
(x) Effects of individual carotenoids on the absorption, bind-
ing, transport and bioactivation of other carotenoids as
well as selective absorption, binding, transport and bioac-
tivation of individual carotenoids [33].
(xi) Any factor associated with vitamin A/retinoid storage and
metabolism.
Thus, as individual responses can depend on many vary-
ing factors, it is paramount to understand these and their
influence on the biological variability of carotenoid ADME.
In this review, it is aimed to highlight known host-related fac-
tors that predispose for variations in carotenoid metabolism,
such as genetic factors (e.g. single nucleotide polymorphisms
(SNPs)), though additional ones (disease state, body weight,
smoking, physical activity etc.) are also briefly reviewed. The
manuscript structure is oriented around the metabolic path
of carotenoids, fromdigestion (chapter 2) to intestinal absorp-
tion (chapter 3) and further transport to the liver (chapter 4)
and distribution to target tissues (chapter 5) to storage and
excretion related pathways (chapter 6). Searched databased in-
cludedPubmed andScopus, for all years, in English language,
employing the following search terms (abstract and title) to
start with: “Human* AND (lutein OR lycopene OR xantho-
phyll OR carotene*) AND (bioavailab* OR pharmacokinetic*
OR kinetic*OR absorptionORpostprandial ORmetabol*OR
microb* OR microflora OR biliary OR enterhohepatic* OR
chylomicron OR plasma OR tissue OR metabolism OR ente-
rocyte OR lipoproteins OR transporters OR Single nucleotide
polymorphism* OR genetic varia* OR SNP OR cleavage OR
enzym* OR intestine) AND (intra* OR inter*) NOT (drug-
interaction OR in-vitro)”, though additional literature follow-
ing the primary search results were surveyed.
2 Host factors influencing digestion
aspects – from matrix release to
bioaccessibility
2.1 General aspects and oral phase of digestion
Bioavailability of carotenoids depends on their bioacces-
sibility, i.e. the release from the food matrix and subse-
quent availability for absorption. As carotenoids are apolar,
with octanol/water partition coefficients of 8–12 [47], their
C© 2017 The Authors. Molecular Nutrition & Food Research published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.mnf-journal.com
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Table 2. Studies investigating the variability of carotenoids in blood and target tissues, following intervention trials and observational
studies
Study design Carotenoid(s) Tissue/Compartment Variability Reference
Observational: 901adult
subjects during 4 years
(male, female)
Lycopene, lutein,
-carotene,
-carotene,
-cryptoxanthin
Plasma conc. Intraindividual variance:
Lutein/zeaxanthin: 20.7%
-carotene: 21.0%
 -carotene: 21.9%
Lycopene: 35.0%
-cryptoxanthin: 27.1%
Interindividual variance:
Lutein/zeaxanthin: 70.5%
-carotene: 70.7%
 -carotene: 67.5%
Lycopene: 61.0%
-cryptoxanthin: 66.6%
[284]
Observational: 381 adult
women, 4-month intervals, 4
visits
Lutein Plasma conc. Interindividual: 47% RSD
Intraindividual: 44% of
interind. variation
[243]
-carotene Plasma conc. Interindividual: 80%RSD
Intraindividual: 34% of
interind. variation
Lycopene Plasma conc. Interindividual: 41% RSD
Intraindividual: as interind.
variation
Observational: 21 adult
subjects over 1 year (male,
female), 6 measurements
-carotene Plasma conc. Interindividual: 100% RSD
Intraindividual: 21% of
interind. variation
[244]
Lycopene Plasma conc. Interindividual: 42%
Intraindividual: 72% of
interind. variation
Double stable isotope to 11
healthy men (37mol
-carotene)
-carotene Plasma AUC Interindividual: 137%%RSD
300 fold differences in AUC
dose response observed
[13]
Intervention: 8 adult subjects (4
males, 4 females), 0.5
mol/kg bw.
-carotene Plasma AUC Intraindividual: 68% RSD [159]
Intervention: 8 adult subjects,
0.5 mol/kg bw.
Lutein Plasma AUC Intraindividual: 43% RSD
Administration of isotopically
labelled lycopene (10.2 mg)
to 8 subjects (4 males, 4
females)
Lycopene Absorption % based
on plasma AUC
Interindividual: 504% RSD
for all trans-lycopene
[15]
Administration of lycopene
(10-120 mg) in a tomato
beverage (5 male adults)
Lycopene Absorption (%) Interindividual: 77% RSD
for highest dose, 53%
RSD for lowest dose
[160]
Administration of soup, juice or
tablets to 6 adult males (ca.
20 mg lycopene)
Lycopene Plasma AUC Interindividual: <28% RSD [285]
Feeding trial (5 weeks, 9 mg
lutein/d) to young males
Lutein Plasma conc. Interindividual: ca. 70%
RSD
[286]
Administration of tomato
puree, spinach (12 mg
-carotene, 8 mg lutein), and
pills containing -carotene
and lutein (20 young females)
Lycopene
-carotene
Lutein
Plasma
Plasma
TRL AUC
Interindividual: 40 % RSD
Interindividual: 40% RSD
Interindividual: ca. 45%
RSD from spinach
[147]
Administration of tomato puree
to 33 adult men (0.4 mg
-carotene)
-carotene TRL AUC Interindividual: 105% RSD [32]
C© 2017 The Authors. Molecular Nutrition & Food Research published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.mnf-journal.com
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Table 2. Continued
Study design Carotenoid(s) Tissue/Compartment Variability Reference
-arotene in oil within a meal
(120 mg), 80 males
-carotene TRL AUC Interindividual: 61% RSD [287]
Administration of tomato sauce
(17 mg -carotene) to 12
adults (male, female)
-carotene TRL AUC Interindividual: 64% RSD [149]
Administration of tomato
puree, 33 adult men, 10 mg
lycopene
Lycopene TRL AUC Interindividual: 70% RSD [73]
Administration of tomato juice
to n = 18 adults (male,
female). Ca. 22 mg lycopene
Lycopene TRL AUC Interindividual: <67% RSD [288]
Administration of tomato sauce
to 12 adults (male, female).
Ca. 47 mg lycopene
Lycopene TRL AUC Interindividual fractional
absorption: 2.4% (RSD:
83%)
[148]
Administration of tomato
preparations to 30 adult men,
25 mg lycopene
Lycopene TRL AUC Interindividual: 96% RSD
for tomato paste
[289]
Administration of supplement
(s) or tomato puree (tp) to 39
healthy men, ca. 5 mg lutein
Lutein TRL AUC Interindividual: RSD of 75%
and 137% for s and tp,
respectively
[14]
Administration of salad and
avocado oil to n = 11 healthy
subjects (male, female). 12
mg -carotene, 6 mg lutein, 7
mg  -carotene
Lutein
-carotene
-carotene
TRL AUC
TRL AUC
TRL AUC
Interindividual RSD: 54%
69%
82%
[290]
Administration of tomato
puree, carrots, spinach,
intragastrically to 10 adult
males. 10 mg of each
carotenoid
Lycopene
Lutein
-carotene
Duodenum, micellar
phase
Interindividual RSD: 32%
23%
20%
[66]
Observational, 20 ceased
subjects (male, female), 0.4
months-86 years of age
Lycopene
-carotene
-carotene
Lutein
-cryptoxanthin
Liver Interindividual RSD: 123%
124%
149%
123%
243%
[173]
Observational, 15 ceased adults
(male, female), 0.4
months-86 years of age
Lycopene
-carotene
-carotene
Lutein
-cryptoxanthin
Kidney Interindividual RSD: 100%
132%
132%
234%
234%
[173]
Observational, 13 ceased adults
(male, female), 0.4
months-86 years of age
Lycopene
-carotene
-carotene
Lutein
-cryptoxanthin
Lung Interindividual: 196% RSD
125%
117%
136%
180%
[173]
Intervention: 30 mg
-carotene/d for 43 days in
patients with adenomatous
polyps (n = 7, male, female)
Lutein/zeaxanthin
-cryptoxanthin
Lycopene
-carotene
-carotene
Colon Interindividual RSD: 71%
126%
68%
76%
66%
[291]
incorporation into mixed micelles is necessary prior to their
cellular uptake,which is assumed to take place predominantly
in the small intestine.
Mastication during oral digestion results in enhanced sur-
face area and the breakdown into smaller particles. In ad-
dition, saliva appears to contain some lipase activity [48],
though not necessarily lingual lipase (a triacylglycerol-lipase,
EC 3.1.1.3) [49, 50] (Table 3). As exposure in the oral cavity
is rather short (usually less than 1 min), the enzymatic ef-
fect on carotenoid bioavailability is presumably small, though
smaller particle size has been related to improved carotenoid
bioavailability [51]. To our knowledge, no mutagenesis on or
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Table 3. Host factors influencing carotenoid release from food matrix and bioaccessibility
Phase of
digestion
Factor Study description Carotenoids
investigated
Possible role in
bioavailability
Reference
Oral Lingual lipase, other
lipase
No data available n/n Low n/n
-amylase No data available n/n Low n/n
Gastric Non-dietary
phospholipids/
mucin
No data available n/n Low compared to dietary
phospholipids
n/n
Gastric lipase (GL) GL from fungi (Rhizopus
oryzae), pH optimum
5–9, in-vitro
-carotene No effect of gastric lipase
detected
[64]
Pepsin No effect in in vitro trials Lutein, -carotene,
lycopene
Presumable low effect in
most carotenoid rich
foods
[57,58]
Pepsin Tomato puree in vitro Lycopene Enhancing effect on
lycopene micellization
[59]
pH Digestion of spinach, in
vitro
-carotene, lutein Presumably negligibleb),
though extreme pH may
facilitate degradation
[55,292]
Duodenum Pancreatic lipase Digestion of spinach, in
vitro
-carotene, lutein,
zeaxanthin
Low micellization (<5%
original conc.) without
pancreatina)
[57]
Digestion of
carrots+spinach+
tomato, in vitro
Total carotenoids Micellization drop to 50%
without pancreatin
[58]
Pancreatic amylase Intake of amylase
inhibitor ascarbose
reduced vit. A levels in
blood
Only vit. A Low [293]
Pancreatic
proteases, PLRP2
No data available n/n Low n/n
Pancreatic colipase Tomato puree, in vitro
digestion
Lycopene Reduced intestinal
recovery without
colipase, no effect on
micellization
[59]
Carboxyl-esterase Digestion of wolfberry,
pepper, squash in vitro
Zeaxanthin-esters Enhanced xanthophyll
bioavailability
[77]
Bile salts Digestion of spinach, in
vitro
-carotene, lutein,
zeaxanthin
Micellization drop to 30%
original conc. without
bile salts
[57]
Bile salts Digestion of
carrots+spinach+
tomato, in vitro
Total carotenoids Low micellization (<2%
original conc.) without
bile extract
[58]
Colon Microbiota Lower circulating
carotenoids in subjects
with higher Collinsella
and atherosclerosis
-carotene Unclear [133]
Microbiota Higher liver storage of 
-and -carotene in
germ-free rats
-, -carotene Prevention of breakdown
products? Transit time?
Bile-salts?
[45]
n/n: no data available.
a) though containing also other enzymes, pancreatic lipase is presumably the enzyme most important for carotenoid digestion.
b) except for epoxy-carotenoids (violaxanthin, neoxanthin).
polymorphisms with effects on oral lipases and lipid diges-
tion has been reported to date.
As salivary alpha-amylase (EC 3.2.1.1) participates in the
break-down of starch, food matrices rich in both starch and
carotenoids, such as sweet potato, may be influenced by
alterations in alpha-amylase levels. It has been reported that
in populations traditionally exposed to high levels of starch,
more copies of the salivary amylase gene (AMY1) and higher
enzyme levels were found [52], though its influence on the
digestion of carotenoids has never been investigated.
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2.2 Gastric phase of digestion
In the stomach, the primary digestion enzymes include
pepsin (3.4.23.1) and gastric lipase (3.1.1.3), though orally se-
creted lipases may still be active. In addition, a small amount
of phospholipids [53] is released from the mucus layer [54],
aiding in the emulsification of lipophilic constituents. The
pHmay have an influence, as low pH can result in the degra-
dation of epoxy-carotenoids (e.g. violaxanthin, neoxanthin),
resulting in epoxide-furanoid transitions [55]. Human gas-
tric pH is influenced mostly by meal, with a complex meal
increasing the pH from initially 2 to 3–5, though interindi-
vidual differences in fasting pH exist [35].
A few native foods are rich in both proteins and
carotenoids, including egg yolk, salmon, and some types of
cheese, and protein digestion could contribute to the release
of carotenoids. In addition, (partly) digested proteins may
aid in emulsifying carotenoids [51]. Expression of pepsin has
been reported to depend on the pepsinogen genes PGA3,
PGA4, PGA5, and progastricsin (PGC) [56]. However, vary-
ing the amount of pepsin in in vitro trials did not appear to
have measurable effects on carotenoid bioaccessibility from
leafy vegetables [57], and at least for such and similar sources,
variations in pepsin are not expected to contribute to plasma
level variability. Similarly, using a test meal composed of
meat, carrots, spinach and tomato paste, gastric digestion
(in vitro) had no significant influence on carotenoid bioac-
cessibility [58], suggesting rather small effects on carotenoid
bioavailability at this step, though in these trials, gastric li-
pase was not involved. By contrast, Periago et al. [59] reported
a positive effect of pepsin on lycopene micellization from a
puree in vitro. It is possible that for this very apolar carotenoid,
protein degradation products added to the emulsifying effect,
or aided in matrix breakdown.
The genes related to the production and secretion of mu-
cus containing phospholipids, which could aid in the emul-
sification process, are not clearly identified. Concentration
variations of phospholipids between 0.03 and 0.6 mM have
been reported, [60] and may be expected to have some influ-
ence on carotenoid micellization. However, their influence
and strengths of effect are unknown and would also be su-
perseded by dietary phospholipids, which are expected to play
a more important role. This would be true especially follow-
ing ingestion of lipid-rich meals (a mean intake of 2–8 g/d
of phosphatidylcholine has been reported [61], which would
translate into ca. 8mM (if taken within 1 out of 3majormeals
per day, and dissolved in 1 L gastric fluid).
Gastric lipase, encoded by the LIPF (lipase F, gastric type)
gene [62] and secreted by gastric chief cells, can digest up to
25% of the ingested lipids [35]. It thus could be expected to
influence the accumulation of carotenoids in lipid droplets,
and their degradation, important for the following transition
of carotenoids from lipid droplets to mixed micelles. This
occurs mostly in the small intestine. Unfortunately, gastric
lipase cannot, at present, be studied in vitro, due to the un-
availability of human gastric lipase. Other sources, such as
those from fungi, have different cleavage kinetics, differing
in their pH optimum and also the type sequence of cleavage
[63]. Rabbit lipase would be an interesting option, but is not
commercially available. Some, such as lipase from the fun-
gus Rhizopus oryzae have been tested (cleavage optimum pH
5–9), though no significant improvement in bioaccessibility
was found [64].
2.3 Small intestinal phase of digestion
The most crucial step influencing carotenoid bioacessibility
is the small intestinal phase. Here, micellization occurs or
is completed, following the secretion of bile salts, in addi-
tion to pancreatic lipase, and additional enzymes (pancreatic
amylase, nucleosidases, trypsinogen, chymotrypsinogen, car-
boxypeptidase, elastases, phospholipases, and carboxyl ester
lipase). Bile salts aid in the emulsification process and for-
mation and stability of the mixed micelles, while pancreatic
lipase produces free fatty acids andmonoglycerides, fostering
emulsification. Thus, it can be expected that modifications of
both bile-acid and pancreatic lipase secretions have strong
effects on the micellization of carotenoids, a pre-requisite for
their diffusion to the unstirred water layer prior to absorp-
tion [65]. This has been confirmed by several in vitro stud-
ies, where micellization and resulting bioaccessibility was
very much compromised when either bile salts or pancre-
atic lipase were missing. Without bile, bioaccessibility of to-
tal carotenoids fell to 30%, and without pancreatic lipase or
both, to below 5% of their original value [57]. Similar strong
effect were found by Garret et al. [58], where total carotenoid
micellization dropped below 5% of the original values
without bile salts. The effect of pancreatin was less drastic
(reduction by approximately 50%), possibly due to differences
between test meals. In order to study factors influencing
lycopene bioaccessibility, tomato puree was digested under
various conditions, testing among other factors gastric pH,
gastric digestion time, pepsin concentration, intestinal pH,
pancreatin concentration, bile salt concentration, colipase ad-
dition and intestinal digestion time [59]. It was found that only
pepsin positively influenced micellization, while olive oil had
a slightly negative effect, likely due to entrapment of lycopene
by non-hydrolysed olive oil.
Following intragastric in vivo administration of carotenoid
rich meals, duodenal fluid was aspirated, and micellization
determined [66]. Variability between subjects’ micellization
efficacy (fractional bioaccessibility) was considerably lower
compared to plasma or triacylglycerol-rich lipoprotein (TRL)
carotenoid variability following interventions, being 20, 23,
and 32%, respectively for -carotene, lutein and lycopene,
vs. typically 50–80% for plasma, though variations between
studies can be considerable (Table 3). Thismay point out that,
although enzyme or bile salt concentrations surely play a role
in interindividual variation, an additional and about equal
portion of variability is added during and after absorption.
C© 2017 The Authors. Molecular Nutrition & Food Research published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.mnf-journal.com
Mol. Nutr. Food Res. 61, 6, 2017, 1600685 (10 of 37) 1600685
Bile acid production by the liver is governed by a variety
of genes, involving for instance bile acid synthetic enzyme
(CYP7A1), activators of CYP7A1 expression such as HNF4
(hepatocyte nuclear factor 4 alpha, encoded by HNF4A), and
PGC1 (encoded by PPARGC1A), repressors of CYP7A1
(farnesoid X receptor (FXR, encoded by NR1H4)), short het-
erodimer partner (SHP, encoded by NR0B2), G protein path-
way suppressor 2 (GPS 2, encoded by GPS2), pregnane X
receptor (PXR, encoded by NR1I2), fibroblast growth factor
19 (FGF19; encoded by FGF19), fibroblast growth factor re-
ceptor 4 (FGFR4; encoded by FGFR4), klotho B (encoded by
KLB), and forkhead box O1 (FOXO1; encoded by FOXO1)
[67], however, their role in carotenoid absorption and tissue
variability has not been examined.
At least three lipases are secreted from the pancreas,
including pancreatic triglyceride lipase (encoded by PN-
LIP), which is the most abundant lipase (producing sn2-
monoacylglycerol and free fatty acids), but also two homo-
logues, pancreatic lipase-related proteins 1 (not apparently ac-
tive regarding lipolysis) and 2 (PLRP1 andPLRP2) [68]. PLRP2
possess a broader substrate specificity, also cleaving, unlike
PNLIP, phospholipids and galactolipids. The frequency of a
SNP in the PLRP2 gene (rs4751995) has been associated with
populations historically consuming a diet rich in cereals, and
may have repercussions on lipid digestion [69].
Though pancreatic triglyceride lipase activity is usually
reduced by bile-salts, this effect is offset by colipase, also se-
creted by the pancreas [70]. Formation of colipase preprotein
is regulated by the CLPS gene, and mice deficient for CLPS
showed lower survival and weight gain on a high-fat diet,
suggesting the inability to cope with lipids on a high fat diet
[71]. A polymorphism for the gene encoding procolipase has
been related to lipid metabolism and diabetes risk [72], and
would be an interesting candidate also regarding carotenoid
metabolism. In a recent study, a SNP in PNLIP (rs11197742)
was found in a combination of SNPs associated with chy-
lomicron secretion of lycopene [73], although its contribution
was rather low and did not reach statistical significance when
investigated individually (p = 0.086). Several SNPs in PNLIP
have been reported in children, and the latter was related to al-
tered plasma lipoprotein and total cholesterol concentrations
[74], as well as with lycopene bioavailability (Table 4).
Carboxyl-ester lipase (CEL), also termed cholesterol-
esterase, typically cleaves cholesterol esters in the gut, and its
ability to cleave carotenoid esters, such as of lutein, present
in many leafy vegetables, has been controversially discussed
[75]. At least five types of CEL are known, though human
carboxylesterases CES1 and CES2 may play the most impor-
tant role during digestion [76]. These are situated on the gut
mucosa (brush border enzymes), and have shown to cleave
carotenoid esters [77]. Its origin (pancreatic vs. enterocyte)
remains somewhat unclear. However, this cleavage is ex-
pected to influence bioavailability, as the more apolar esters
are characterized by lower micellization efficiency and ab-
sorption than the cleaved carotenoids [78]. In fact, in plasma
and circulating chylomicrons, free xanthophylls are almost
exclusively found, suggesting that cleavage is in fact quite
complete [79], though reduced absorption of the esters could
play a role. Anumber of SNPshave been described in humans
for CES1 and CES2 [80], though not in relation to carotenoid
or lipophilic phytochemical/micronutrient metabolism.
Certain diseases such as pancreatitis may also result in
lower secretion of digestion enzymes [81]. Also during older
age reduction of lipid absorption has been reported, perhaps
also due to reduced epithelial surface [82], which may thus
be expected to correlate with lower carotenoid absorption, as
suggested by some, though not all studies (Table 1).
3 Host factors determining aspects
of intestinal absorption
3.1 Factors influencing cellular uptake and cleavage
Following their extraction from the food matrix and incorpo-
ration, at least in part, into mixed micelles, carotenoids are
taken up by enterocytes. This process is not only passive, as
previously thought [83], and several apical membrane pro-
teins have been shown to facilitate carotenoid uptake [36].
SR-BI, encoded by SCARB1, is involved in the uptake of -
carotene [84,85], lutein [86] and lycopene [87]. CD36 facilitates
-carotene [84] uptake and could facilitate lycopene uptake
[88], while NPC1L1 participates in the uptake of lutein [89].
All of these proteins have SNPs in their encoding genes asso-
ciated with carotenoid plasma concentrations (Table 4), and
their contribution to carotenoid uptake has been confirmed
in cellular models (e.g. human Caco-2 cell line), but also in
models employing transfected kidney (HEK) cells. After en-
terocyte uptake, carotenoids can be metabolized by BCO1
[90] and BCO2 [39]. BCO1 catalyses the oxidative cleavage of
provitamin A carotenoids (chiefly -carotene, -carotene, -
cryptoxanthin), apo-carotenals, and lycopene, but not that of
lutein [91]. BCO1 is presumably the main cleaving-enzyme
for -carotene [92]. Lycopene was suggested to be predomi-
nantly cleaved by BCO2 [93], while recently lycopene cleavage
by BCO1 was also reported [94]. However, until now no ly-
copene derived BCO1-products were determined [95,96] and
were only postulated [97, 98]. BCO2 has also been shown to
be involved in lutein metabolism [99]. Most -carotene con-
version (>70%) is thought to occur in the intestine; by using
stable isotope techniques it was estimated that about 20–30%
occurs after absorption [100], contributing to overall vitamin
A homeostasis. In addition, a controlled temporal and spa-
tial conversion of carotenoids to bioactive retinoids is also of
physiological importance, indicated by a specific pattern of
BCO1 expression in various tissues [101]. This expression is
linked to RAR-mediated signaling [39, 102].
The involvement of several proteins in the intestinal ab-
sorption of carotenoids (apical uptake) suggests that varia-
tions in the genes encoding these proteins could modulate
carotenoid absorption efficiency. This has been confirmed in
an association study by Borel et al. [103] where the influence
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Table 4. List of SNPs known, or speculated, to influence carotenoid metabolism
Aspect of
bioavailability
Gene SNP Carotenoid/other Function Reference
Digestion PNLIP rs11197742 Lycopenec) Pancreatic lipase [73]
96A/Ca) exon 3 [74]
486C/T exon 6 [74]
1359C/T exon 13 Plasma lipoproteins [74]
CLPS Arg92Cys (rs370885215) Cholesterol,
apolipoproteinsd)
Colipase [72]
LIPF unknown unknown Gastric lipase [46]
Absorption SCARB1f) Intron-5 -carotened) Transporter [103]
Allele A, exon 1 -cryptoxanthind) [103]
Allele T, exon 8 -cryptoxanthind) [103]
rs11057820 Luteine) [294]
rs11057841 Luteind) [294]
rs10773109 Luteind) [294]
rs11057830 Luteind) [294]
rs11608336 Luteind) [294]
rs12581963 Luteind) [294]
rs10846744 Lutein/zeaxd) [295]
rs11057841 Lycopened) [296]
rs61932577 -carotene, -carotened) [84]
rs5888 -cryptoxanthin [84]
CD36f) rs4112274 Lycopenec) Transporter [73]
rs1524598 Lutein/zeaxanthind) [295]
rs1761667 Lutein/zeaxanthind) [215]
rs13230419 Lutein/zeaxanthind) [215]
rs1761667 Lutein/zeaxanthine) [215]
rs1984112 -cryptoxanthind) [84]
rs1761667 -cryptoxanthind) [84]
rs7755 -cryptoxanthind) [84]
rs1984112 -carotened) [84]
rs1761667 -carotened) [84]
rs1527479 -carotened) [84]
NPC1L1 rs17725246 Lycopenec) Transporter [73]
rs217430 Lutein/zeaxd) [295]
rs217428 Luteind) ?h) [215]
rs17655652 Luteind)? [215]
rs217434 Luteind)? [215]
ABCG5 rs2278357 -carotenec) Transporter [32]
rs10205816 Lutein/zeaxanthind) [295]
ABCG8 rs13405698 Lutein/zeaxanthind) [295]
rs4953028 Lutein/zeaxanthind) [295]
rs4148211 Luteind) ? [215]
rs4148217 Luteind) ? [215]
rs6544718 Luteind) ? [215]
ABCG2 rs17731631 Luteinc) Transporter [14]
rs6532059 Luteinc) [14]
rs1871744 Lycopenec) [73]
ABCA1 rs2791952 -carotenec), lycopenec) Transporter [32,73]
rs1331924 Lycopenec) [73]
rs10991408 -carotenec) [32]
rs3887137 -carotenec), lycopenec) [32,73]
rs390253 Luteinc) [14]
rs4149316 Luteinc), lycopenec) [73]
rs4149299 Lycopenec)
rs9919066 Luteinc) [14]
rs2020926 Luteinc) [14]
rs2274873 Lutein/zeaxanthind) [295]
rs1331924 Lutein/zeaxanthind) [295]
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Table 4. Continued
Aspect of
bioavailability
Gene SNP Carotenoid/other Function Reference
ABCB1 rs10248420 Lycopenec) [73]
rs10280101 Lycopenec) [73]
ISXg) rs137252 Luteinc) Regulates BCO1 [14]
rs5749706 Luteinc) Expression [14]
rs137269 Luteinc) [14]
rs137238 Luteinc) [14]
rs5755368 -carotenec), luteinc) [14,32]
rs202313 -carotenec) [32]
rs16994824 -carotenec) [32]
rs2056983 Lycopenec) [73]
Intracellular
cleavage
BCO1 rs7196470 -carotenec) Cleavage enzyme [32]
promotor -carotened) [107]
rs11645428 Lutein/zeaxanthind) [295]
rs6564851 Lutein/zeaxanthind) [295]
rs7500996 Lutein/zeaxanthind) [295]
rs6564851 -carotene, -carotene,
lycopene, zeaxanthin,
luteind)
[32,104]
rs4889286 -carotened) [297]
rs12934922 -carotened) [297]
rs4889293 -carotened) [297]
rs4889286 -carotened) [297]
rs12918164 -cryptoxanthind) [297]
rs4889293 -cryptoxanthind) [297]
rs56389940 Lutein/zeaxanthind) [297]
rs10048138 Lutein/zeaxanthind) [297]
rs7501331 Luteind),e) [215]
rs12934922 -carotened) [298]
rs7501331 -carotened) [298]
rs12934922 -carotened) [298]
BCO2 rs12796114 Association with AMD Cleavage enzyme [295]
rs2250417 Association with AMD [295]
Intracellular
transport (gut
epithelium) and
other functions
ELOVL2 rs9468304 -carotenec), luteinc) Fatty acid
elongase,
precursor
membrane
[14,32]
Lycopenec) Lipids [73]
rs3798709 -carotenec), luteinc),
lycopenec)
[14,32,73]
rs911196 -carotenec), lycopenec) [73]
INSIG2 rs17006621 Luteinc), lycopenec) Sterol binding [14]
I-FABP IFABP-Thr Lycopened) Fatty acid
transport
[103]
SLC27A6 rs10053477 Lycopenec) Fatty acid
transport
[73]
Chylomicron
secretion
MTP rs17029213 Luteinc) Triglyceride [14]
rs17029173 Lycopenec) Transporter [73]
rs1032355 Lycopenec) [73]
rs745075 Lycopenec) [73]
Blood, liver
metabolism,
lipoprotein
distribution
LPL rs7821631 Luteinc) Lipoprotein lipase [14]
rs10096561 Luteinc) [14]
rs1441778 Luteinc) [14]
rs7841189 Lycopenec) [73]
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Table 4. Continued
Aspect of
bioavailability
Gene SNP Carotenoid/other Function Reference
rs7005359 Lycopenec) [73]
rs17482753 Lycopenec) [73]
X447 allele Lutein, -carotene,
-carotene,
-cryptoxanthinb)
[162]
APOA1 rs2070665 Luteinc) Protein of HDL [14]
APOA4 Ser-347 Lycopened) Chylomicron
protein
[103]
APOE ɛ4 AMD Chylomicron
protein
[295]
APOB rs1042031 -carotenec), lycopenec) Protein of LDL,
VLDL,
chylomicrons
[32,73]
rs4643493 -carotenec) [32]
rs35364714 -carotenec) [32]
rs2854725 Luteinc) [14]
516 -carotened) [103]
516 Lycopened) [103]
LDLR rs6511720 Tocopherol Lipoprotein
receptor
[104]
LIPC rs1869138 -carotenec) Hepatic lipase [32]
rs11857380 -carotenec) [32]
rs12185072 -carotenec) [32]
rs12591216 Luteinc) [14]
rs12593880 Luteinc) [14]
rs8035357 Lycopenec) [73]
rs12914035 Lycopenec) [73]
rs493258 Zeaxanthind) [299]
rs493258 Luteind) [299]
HL C-480T -,-carotene [103]
CYP26B1 rs2241057 Retinol Degradation of
retinol
[182]
CETP rs708272 Lutein/zeaxanthind) Cholesteryl and
perhaps
carotenoids
ester transfer
[295]
Tissue GSTP1 Pi (isoform) Lutein/zeaxanthin Uptake into retina [300]
incorporation STARD3 rs9892427 Lutein/zeaxanthind) Lipid transfer,
binding to retina
[295]
RPE65 rs12139131 -carotenec) [32]
rs4926340 -carotenec) [32]
rs1924546 Luteinc) [14]
rs12744671 Lutein/zeaxanthind) [295]
Other functions SOD2 rs2501175 -carotenec) Antioxidant
enzyme
[32]
rs9365046 Lycopenec) [73]
COBLL1 rs3769877 Luteinc) Insulin
metabolism
[14]
CXCL8 rs1247620  -carotenec) IL-8 precursor [32]
rs1358594  -carotenec) [32]
rs6834586 -carotenec) [32]
TCF7L2 rs946199 -carotenec) Transcription
factor related to
diabetes
[32]
PKD1L2 rs8043708 -carotenec) Related to pore
channels?
[32]
rs12596941 Luteinc) Ion channel? [14]
rs935933 Lycopenec) [73]
C© 2017 The Authors. Molecular Nutrition & Food Research published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.mnf-journal.com
Mol. Nutr. Food Res. 61, 6, 2017, 1600685 (14 of 37) 1600685
Table 4. Continued
Aspect of
bioavailability
Gene SNP Carotenoid/other Function Reference
MC4R rs11873337 Luteinc) Obesity [14]
IRS1 rs2178704 Luteinc) Signal
transduction
[14]
rs1316328 Luteinc) [14]
SETD7 rs7680948 Lycopened) Insulin
metabolism,
inflammation
[296]
a) base-pairs: A: adenine, C: cytosine, T: thymine, G: guanine.
b) in animals, not humans.
c) Measured by chylomicron response.
d) Measured by plasma levels.
e) Related to AMD, Measured as macula pigment optical density (MPOD).
f) also involved in uptake in other tissues
g) Intestine Specific Homeobox.
h) Question mark indicating assumed influence.
of candidate SNPs of genes involved in lipid metabolism on
the fasting blood concentration of several carotenoids was
investigated. More specifically, SNPs in SCARB1 were asso-
ciated with -carotene but not with lycopene concentrations.
These SNPs explained differences in -carotene plasma con-
centrations by up to 50%. Several additional SNPs havemean-
while been identified, including several in BCO1 in genome-
wide association studies [31, 104, 105]. Three recent studies
have reported associations of combinations of SNPs involved
in interindividual variability of the bioavailability of lutein
[14], lycopene [73] and -carotene [32], employing a candidate
gene approach in postprandial studies. In these, plasma-TRL
carotenoids, representing newly absorbed carotenoids, were
measured in healthy male adults. These combinations were
associatedwith 73, 72, and 69%of the interindividual variabil-
ity of the bioavailability of lutein, lycopene and -carotene,
respectively. While some SNPs were located in genes ex-
pressed in other tissues or were closely involved in plasma-
TRLmetabolism, others were involved with carotenoid trans-
port or metabolism at the enterocyte level. These included
ABCA1, ABCG5, BCMO1, CD36, ELOVL2, and ISX (intes-
tine specific homeobox). Interestingly, one SNP in ELOVL2
(rs9468304) was very strongly associated with all three
phenotypes, possibly due to the inhibitory effect of eicosapen-
taenoic acid, which is further elongated to docosapentaenoic
acid and docosahexaenoic acid by ELOVL2, on carotenoid ab-
sorption, as has been shown with -carotene [106].
3.2 Influence of nutritional status
Host vitamin A status has been linked with -carotene ab-
sorption variability. Lobo et al. [107] demonstrated that the in-
testinal transcription factor ISX acts as a repressor of SCARBI
and BCO1 expression following retinoic acid induction. This
mechanism is thought to serve as a negative feedback loop
regulating retinal and further retinoic acid, retinyl esters and
retinol status throughmodulation of provitaminA carotenoid
absorption and cleavage efficiencies. Interestingly, the same
team has reported the existence of an SNP in the ISX binding
site in the BCO1 promoter (rs6564851) which was associated
with decreased conversion rates by 50% and increased fasting
blood levels of -carotene [108].
Though the mechanisms are not fully elucidated, low iron
status was suggested to interact with retinol homeostasis, re-
sulting in decreased mobilization of liver vitamin A and thus
low serum concentrations [109], possibly involving altered
BCO1 activity [110]. Also a low zinc status appears to reduce
-carotene absorption from the gut [111], perhaps as phos-
pholipase A2 can bind zinc and may be more active. These
effects were confirmed in human studies, where supplemen-
tation with iron and zinc following a vitamin A deficient diet
improved retinol and carotenoid plasma appearance, respec-
tively [112]. Also low protein status appears to hinder conver-
sion of -carotene to vitamin A, contributing to carotenoid
variability [113].
BCO1 and BCO2 were also described to be controlled by
peroxisome proliferator-activated receptor (PPAR) – retinoid
X receptor (RXR) mediated signaling [114, 115]. The endoge-
nous ligands of the PPARs , / and  are ranging from
free fatty acids to various eicosanoids such as prostaglandins,
leukotrienes and mono-hydroxylated fatty acids [116]. The
RXR was described to be activated by 9-cis-retinoic acid
(9CRA) [117], as well as the newly found endogenous rele-
vant ligand 9-cis-13, 14-dihydro-retinoic acid/9CDHRA [118].
It is debated whether 9CRA occurs endogenously [119]. Cur-
rently, 9CRA is considered mainly as a ligand that is present
after highnon-physiological andnon-nutritional relevant vita-
min A intake, leaving 9CDHRA as the principal endogenous
and the nutritional relevant RXR ligand. PPAR ligands are
mainly food derived [116], while the nutritional precursors
of the endogenous RXR ligand 9CDHRA were not yet iden-
tified. The PPAR-regulatory pathway of BCO1/2 expression
and further carotenoid bioactivation is thus controlled by the
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amount and fractional distribution of lipids present in the
food matrix. In addition to genomic regulation of BCO1/2
expression, carotenoid cleavage can also be modulated by in-
hibitory effects of lutein on -carotene cleavage [120]. This
indicated that not just the individual carotenoid concentra-
tion is of relevance to bioactivation towards retinoic acid and
further transcriptomic regulation, but also the concentration
of carotenoids inhibiting this metabolic step, as well as their
concentration relative to -carotene. The consequences of
BCO1/2 mediated regulation of retinoic acid synthesis and
further transcriptional signaling by additional factors and its
consequences for our health will be discussed later (chapter
7), highlighting the special importance of BCO1/2 on explain-
ing interindividual variability, likely related to the beneficial
health effects of carotenoids.
3.3 Colonic fermentation as an interindividual
source
To date, it is unclear to what extent the microbiota con-
tributes to carotenoid metabolism, and whether carotenoids/
their metabolites can be taken up in the colon. It is known
that a large proportion of carotenoids reaches the colon,
as only 5–50% are absorbed in the small intestine. It is
also known that carotenoids are partly bioaccessible in the
colon [121]. However, only 10–50% of the carotenoids re-
main intact after fermentation, while the remainder reacts
to unknown compounds [121–123]. This was supported by
carotenoid standards as the only fermentation source in vitro,
as >98% losses for -carotene and zeaxanthin were reported
[123].
Very little is known on carotenoid interaction with the mi-
crobiota [124]. Unlike polyphenols, which are heavily metab-
olized, no carotenoid degradation products/bacterial metabo-
lites have been identified. In general, bacteria in the colon are
able to deglycosylate, hydrolyse, deglucuronidate, demethy-
late, and cause ring-fission in some molecules, among other
[46, 125]. However, in germ-free rats, higher carotenoid uti-
lization (of - and -carotene) as measured by their liver lev-
els, has been reported compared to rats with intactmicrobiota
[45]. It was suggested that indirect effects, such as decreased
intestinal transit time and an altered bile pool in the absence
of bacteria could have played a role, though a reduced level
of bacterial breakdown products and more remaining native
compounds could have been involved. In support of a poten-
tial absorption of carotenoids in the colon, a study in mice
found BCO1 to be expressed in many cells including mu-
cosal, glandular cells in the stomach, small intestine, and
the colon [126]. BCO2 is known to be expressed in almost
all cell types known to express BCO1. However, BCO2 was
not found in the colon, suggesting that only symmetric cleav-
age of carotenoids may happen in the mucosal cells in the
colon.
In a previous study, -carotene uptake into human ex-
foliated epithelial cells of the colon, separated from feces,
has been demonstrated [127]. Following the consumption
of -carotene rich spirulina, the concentration of -carotene
in the cells increased approximately 3-fold, demonstrating
colonic cellular presence. However, this may have occurred
not necessarily through direct cellular uptake via colonocytes,
as carotenoids could have been absorbed via the small intes-
tine and then distributed via the circulatory system to the
colonocytes. Furthermore, the same constituents known to
enhance carotenoid bioavailability, namely bile salts, emul-
sifiers such as lecithin [128, 129], enhanced colonic cellular
uptake. Though carotenoids can be taken up by colonic de-
rived Caco-2 cells, direct colonic uptake is not easy to prove,
and studies so far have not suggested a strong correlation be-
tween dietary intake of carotenoids and colon concentrations
[130]. Oshima et al. [131] investigated colonic absorption and
distribution of lycopene in rats with or without a colostomy
at mid colon that diverted the fecal stream but without resec-
tion of the distal colon. In rats given intragastric treatment,
lycopene was found in the mucosa in the proximal colon and
in the distal colon, also of the colostomized rats, whose dis-
tal colon was isolated from the faecal stream, indicating that
lycopene may be transported via the blood into the colon.
Moreover, lycopene reached the liver to an appreciable ex-
tent even when administered into the isolated distal colon,
indicating that absorption is possible from the distal colon in
rats.
Taken together, these results indicate that carotenoid ab-
sorption from the colon could be relevant and contribute
to interindividual variation in carotenoid bioavailability, de-
pending on the food matrix and microbiota. Furthermore, as
faecal transplants have shown to be able to trigger obesity, at
least in animalmodels [132], and obese subjects having gener-
ally lower concentrations of circulating carotenoids (Table 1),
a potential direct or indirect link between the microbiota and
carotenoid tissue levels may exist. In a study with atheroscle-
rotic subjects, patients showed a metagenome with reduced
phytoene-dehydrogenase and lower -carotene serum levels
compared to healthy controls, which was associated with a
higher level of Collinsella spp. in diseased subjects [133],
highlighting the potential role of the microbiota.
3.4 Diseases and medical intervention effecting the
intestine and colon
Any condition reducing the intestinal mucosal surface area
can be expected to reduce carotenoid absorption. As most
studies do not directly measure carotenoid absorption effi-
ciency but rather look at blood carotenoid levels (or a plasma
fraction), it is important to distinguish between direct effects
on carotenoid absorption (i.e. through reduced mucosal sur-
face area or limited transport capacity) and indirect effects
(through dietary adaptations, e.g. high fiber or low fat diet).
This is usually achieved by controlling for carotenoid dietary
intake.
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A study with 20 Crohn’s disease patients reported lower
fasting blood carotenoid concentrations, independent of di-
etary intake [134], suggesting that malabsorption affected
carotenoid uptake, though increased turnover rate and
colonic losses via e.g. bleeding could not be excluded. Similar
results were obtained by Geerling et al. [135] in a study with
32 Crohn’s disease patients and Genser et al. [136] with 24
patients. Crohn’s disease usually affects the ileum but only
three of the 20 patients in the study had ileal inflammation,
indicating the importance of the colonicmucosal integrity for
carotenoid absorption. Patients undergoing bariatric surgery
(Roux-en-Y gastric bypass and biliopancreatic diversion) also
displayed lower blood carotenoid levels [137]. Since fruit and
vegetable consumption was apparently normal, the effect was
attributed to malabsorption due to reduced mucosal surface
area and also due to limited capacity of transport related to
decreased lipoprotein concentration. Also reduced gastric di-
gestion (via gastric lipase, or mechanic dispersion), could
have played a role, as could have biliopancreatic diversion, af-
fecting bile and pancreatic enzyme concentrations in the gut.
In another study, subjects with Celiac disease and Crohn’s
disease (n = 22) showed significantly 37% decreased levels
of macular carotenoids compared to controls (n = 25 [138].
Short bowel syndrome, usually due to large resections
of the small intestine to treat pathologies such as Crohn’s
disease or gastrointestinal tumors, have also been associ-
ated with carotenoid malabsorption. Edes et al. [139] reported
undetectable -carotene blood levels following supplemen-
tation, despite adequate fat absorption, in a patient with ex-
tensive small intestinal resection (serum vitamin A levels ap-
peared normal). Perhaps carotenoid absorption occurred in a
more limited section of the intestine, or absorbed -carotene
was fully converted to vitamin A. Luo et al. [140] reported
no increase in blood carotenoid levels in subjects with short
bowel syndrome undergoing intestinal rehabilitation, despite
a 12-week-long supplementation with -carotene, lutein and
lycopene. This was attributed to low fat absorption (about 30
versus>95% in healthy subjects) in these patients. However,
no estimates of the contribution of the colon to the observed
differences in absorption efficiencies were reported. There-
fore, it is uncertain if it is the disease affecting the lower gut,
the limited length of residual ileum, the presence or absence
of the colon, the patient’s lifestyle, or a combination that
results in low plasma carotenoids. Similar low levels were
observed in 63 patients with total gastrectomy [141], possibly
due to duodenal bypass and short interposition of a small
intestine loop.
Intestinal parasites and bacterial overgrowth can also dam-
age mucosal cells and result in increased permeability and
decreased absorption of nutrients. In Indonesian children
receiving red sweet potato, serum retinol concentrations in-
creased to a greater extent when children infected with in-
testinal helminths were dewormed, than when the intensity
of infection was high [142], though the effect may have been
also due to improved fat absorption. In tropical countries, also
enteropathies, resulting in inflamed epithelium and reduced
surface available for absorption, are likely to contribute to low
carotenoid and vitamin A status [143].
4 Host factors influencing intracellular
transport and transport to the liver
4.1 Intracellular transport within the enterocyte
After their uptake at the apical side of the enterocyte by mem-
brane proteins, which are involved in the uptake of other li-
posolublemicronutrients, e.g. vitamin E/D [144], carotenoids
have to cross the aqueous environment of the cell to reach
its basolateral side. As carotenoids are very hydrophobic [21]
it is assumed that they need to be associated with intracel-
lular proteins to move through this medium [36]. Though
candidate proteins have been suggested, limited evidence of
their involvement is available yet. A first one is human retinal
lutein-bindingprotein [145], as it shows a good cross-reactivity
with antibodies raised against carotenoid-binding protein,
which has been shown to transport carotenoids in themidgut
cytosol of the silkworm Bombyx mori [146]. However, its ex-
pression in the enterocyte should be verified. Other candi-
dates could be the enterocyte FABPs (FABP2/I-FABP and
FABP1/L-FABP) that allow the transport of various lipids. Fi-
nally, it can be hypothesized that the main enzyme responsi-
ble for carotenoid cleavage in the enterocyte, i.e. BCO1 [39,96],
could also be involved, as it attracts and binds carotenoids for
further cleavage, and it may also function as a non-identified
but predicted selective carotenoid-transporter. The involve-
ment of some of these candidate proteins in carotenoid trans-
port within the enterocyte is supported by studies that have
observed associations between SNPs in genes encoding these
proteins and carotenoid status or bioavailability. This is the
case for FABP and lycopene [103] and BCO1 and -carotene
[32], though this second association can also be due to the
catalytic activity of this protein. Functional studies employing
cell cultures or transgenic mice should be performed to iden-
tify the respective proteins. Nevertheless, it can be hypothe-
sized that variations in genes encoding proteins involved in
the transport of carotenoids within the enterocyte contribute
to the observed interindividual variability in carotenoid
bioavailability.
The previously described interaction of lutein and -
carotene was not investigated further in detail, but it was pre-
dicted also to be of relevance regarding mutual interferences
during absorption [33,120,147]. A different fractional absorp-
tion efficacy was also suggested for cis-isomers of lycopene
[20,148–150]. Unfortunately, for lutein and -carotene as well
as for lycopene and -carotene cis-isomers, themechanism of
this altered transport efficiencywas not examined further, but
it appears to have an important physiological importance due
to the different and possibly augmented health beneficial ef-
fects of especially 9-cis--carotene versus all-trans--carotene,
at least in respect to atherosclerosis [151].
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4.2 Secretion at the basolateral and apical side of
the enterocyte
During the postprandial period following the intake of a meal
providing carotenoids, the latter are recovered in chylomi-
crons and their remnants, circulating in the blood [14,32,73].
This allows physiologists to conclude that carotenoids are
incorporated into chylomicrons within the enterocyte, then
secreted into the lymph, and finally transported to the blood.
Two observations support this paradigm. First, studies on
Caco-2 cell monolayers, an acknowledged model of the hu-
man intestinal epithelium, have shown that carotenoids
added to the apical side of these cells are recovered in the
lipoprotein chylomicron-rich fraction secreted at the baso-
lateral side [152, 153]. Second, clinical studies have shown
associations between SNPs in MTP, involved in chylomi-
cron formation within the enterocyte, and APOB (the main
chylomicron apoprotein), and carotenoid bioavailability [14,
32, 73]. Secretion via chylomicrons implies that polymor-
phisms of genes involved in chylomicron formation, such
as those involved in cholesterol biosynthesis, may poten-
tially have a role in explaining inter-individual variation in
carotenoid uptake or processing, as has been suggested for
patients with hypercholesterolemia [154].
Although it is acknowledged that a significant fraction of
newly absorbed carotenoids is secreted by the enterocyte via
chylomicrons, it should be noted that another fraction is me-
tabolized within the intestinal cell. The size of this fraction
depends on several factors such as the carotenoid species and
the vitamin A status, affecting provitamin A carotenoid ab-
sorption and cleavage [108]. As stated above, BCO1 and BCO2
are responsible for this mechanism. Their action results in
several carotenoidmetabolites, e.g. retinal, apo-carotenals etc.
[155], which may not share a fate similar to that of the par-
ent molecules, and thus are not necessarily incorporated into
chylomicrons. As at least some of these metabolites are water
soluble (logP-values around 5, such as for retinoic acid - 4.4,
http://www.drugbank.ca/drugs/DB00982), it can be hypoth-
esized that they may be secreted to the portal vein and then
reach the liver.
Another pathway involved in carotenoid secretion at the
basolateral side of the enterocyte may be via APOA1. This
involves the membrane protein ABCA1, responsible for the
lipid transfer from this membrane to APOA1/HDL in the
lymph. Though it was shown that ABCA1 is not involved in
the efflux of carotenoids to HDL at the basolateral side of
Caco-2 cells [153], a recent study demonstrated that a fraction
of carotenoids, at least the xanthophylls, is transferred via
ABCA1 to APOA1, not directly to HDL [156].
Thus, the complex mechanisms that are involved in
the secretion of carotenoids, and of their metabolites at
the basolateral side of the enterocyte involve several genes
and are likely to be modulated by genetic variations affect-
ing the expression or activity of the proteins encoded by
these genes. It was thus hypothesized that SNPs in these
genes correlate with interindividual variability of carotenoid
bioavailability. This hypothesis was supported by results of
three recent human clinical studies. These have shown that
SNPs in MTP and in APOB, involved in the APOB depen-
dent pathway, as well as SNPs in ABCA1, involved in the
APOA1 dependent pathway, are associatedwith lutein [14], ly-
copene [73], and-carotene [32] bioavailability. SNPs inAPOB
were associated with -carotene concentrations while SNPs
in apolipoprotein A4 (APOA4) and APOB were associated
with lycopene concentrations [103]. These SNPs explained
differences in e.g. -carotene plasma concentrations by up to
50%.
Finally, carotenoids may also be re-excreted via the apical
side into the gut lumen. Results from a human intervention
trial (with tomato puree) suggested that the ABCB1 gene
plays a key role in lycopene transport, possibly by effluxing
a fraction of the absorbed lycopene back into the intestinal
lumen [73]. This hypothesis needs to be examined further.
4.3 Postprandial chylomicron transport and blood
plasma appearance
It is believed that most newly-absorbed carotenoids are post-
prandially secreted in chylomicrons, and that the role of chy-
lomicrons, among other, is to carry carotenoids and their
lipophilic metabolites from the intestine to the liver. During
their transport, chylomicron triglycerides undergo hydrolysis
by LPL, resulting in the generation of smaller chylomicrons
termed chylomicron remnants. After their uptake by the liver,
a fraction of carotenoids appears to be stored in the liver, an-
other one is metabolized (e.g. into vitamin A for the provita-
minA carotenoids). The remaining fraction is re-secreted into
the blood within VLDL. VLDL, via theirmetabolism into LDL,
are thought to be responsible for the further tissue distribu-
tion of carotenoids. Due to their hydrophobicity, it is thought
that carotenoids stay located within the core of the chylomi-
cron(remnant)s during their transport in blood [157]. Thus,
it is hypothesized that chylomicron carotenoids i) are not sig-
nificantly transferred to other circulating lipoproteins (VLDL,
LDL, HDL), and ii) they are not significantly transferred to
tissues. However, an in vitro study has suggested that this
assumption needs to be revisited because an exchange of
carotenoids between VLDL and HDL was found [158].
Although it is possible that some chylomicron carotenoids
can be transferred to other lipoprotein classes or to tissues
during lipoprotein metabolism, it is assumed that this
transfer is rather limited. Thus, the postprandial blood
metabolism of carotenoids embedded in chylomicrons is
closely related to lipoprotein metabolism. The metabolism
of chylomicrons involves several proteins, starting with the
apolipoproteins that are associated with these lipoparticles
during their synthesis, i.e. APOB48 and APOA1, followed by
the apoproteins that are transferred from other lipoprotein
classes during chylomicron blood transport, e.g. APOE, and
ending with enzymes that transfer or hydrolyse chylomicron
lipids, e.g. cholesterol ester transfer protein (CETP) and
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LPL. Again, it is likely, though not yet demonstrated in
humans, that some carotenoids, i.e. the less hydrophobic
xanthophylls, can transfer from chylomicrons to other
lipoproteins. Furthermore, in vitro data have suggested that
CETP and LCAT (lecithin cholesterol acyl transferase) can
be involved in this transfer [158].
Any variability of affinity of the above-described trans-
porters/proteins involved in chylomicron metabolism would
alter carotenoid kinetics. However, only few human stud-
ies have examined these, including studies on lutein and
-carotene [159], lycopene [160], and also retinyl esters [154].
In the latter study, a 7-compartment model demonstrated a
saturable absorption process, in support of the uptake mostly
via transporters. Variability of absorption was similar over the
range of dosing (10-120 mg), with a relative standard devia-
tion (RSD) of ca. 50%. In an intervention study by Kostic et al.
[159], adult subjects were given single equimolar doses (0.5
mol/kg body weight) of lutein and/or-carotene solubilized
in oil. Absorption had an RSD of 43 and 68%, respectively.
A single peak of mean serum lutein concentration at 16 h
was found, while for -carotene a small initial peak appeared
at 6 h, and a second peak at around 32 h. The first peak
was assumed to be chylomicron-borne, the second peak was
believed to represent newly absorbed -carotene from the
liver circulating as VLDL/HDL [161], whereas the intermedi-
ate peak for lutein was unexplained. This suggests different
mechanisms for the distribution of the two carotenoids, lead-
ing to a different time-course of serum peaks, in line with an
altered transfer between lipoproteins compared to carotenes.
It is unclear whether any differences in serum carotenoids
described in the literature are related to any of the above
proteins involved in uptake, transport and chylomicron
metabolism, but it can be hypothesized. A variety of
apolipoprotein polymorphisms were studied regarding con-
centrations of several carotenoids in children (n = 447), in
a sample of the Stanislas Study. Lower concentrations of
lutein/zeaxanthin (19%), -cryptoxanthin (51%), -carotene
(55%) and -carotene (47%) were found in children express-
ing the S447X allele versus the S447S allele of the LPL
gene [162], though no other correlations were found. In an-
other study [163], human fasting concentrations of - and
-carotene were associated with genetic variants in FABP
and LIPC, while - and - tocopherol were influenced also by
APOC3 (a component of LDL), CETP, andMTP (required for
lipoprotein assembly), indicating that these may be involved
also in carotenoid metabolism. In an earlier study, serum
concentrations of carotenoids (Table 4) were associated with
SNPs in APOB and APOA4 [103].
In addition to these proteins, other factors may play a
role (Table 1). Brady et al. investigated the association be-
tween serum carotenoids and physiological and life-style fac-
tors. Lower serum levels of several carotenes and xantho-
phylls were associated with being male (perhaps related to
lower fruit/vegetable intake), smoker, of younger age, hav-
ing lower non-HDL cholesterol, higher alcohol consumption
and higher body mass; only serum lycopene was not associ-
ated with these factors but with age [164]. Age also showed
to be significantly associated with chylomicron response of
lycopene [165], but not with other carotenoids. However, the
underlying mechanisms of these associations are unclear.
It can be speculated that all factors are related to dietary
pattern, though a higher body mass and a higher amount
of adipose tissue may result in increased carotenoid stor-
age in adipocytes, while smoking may increase the turnover
of carotenoids due to enhanced oxidative stress (Table 1,
[26]). Similarly, in the SU.VI.MAX study (n>12 000 partic-
ipants), it was found that -carotene plasma levels correlated
(negatively) with smoking status, blood triglycerides, alcohol
consumption and age. Again, females had higher -carotene
serum levels thanmen (Table 1).Menstrual cycle also showed
to influence plasma carotenoids. In an intervention trial with
nine women consuming standardized diets for two cycles,
carotenoid plasma concentration was usually lower in the
earlier follicular phase compared to the late follicular phase
and in part higher than in the luteal phase, possibly due to
hormonal influences on the blood concentration of lipopro-
teins as carotenoid carriers [166]. In a larger study, higher
serum retinol levels were associated with higher serum estra-
diol and testosterone levels during the menstrual cycle [167].
5 Further transport and biodistribution to
potential target tissues
5.1 Introduction
Carotenoids are transported in the blood stream associated
with lipoproteins, where carotenes dominate carotenoid pat-
tern in the LDL fraction and xanthophylls are almost equally
distributed between LDL andHDL [168]. Especially the poten-
tial exchange of xanthophylls between lipoproteins is impor-
tant in this context and may depend on the activity of CETP
and LCAT [158]. Consequently, changes of the lipoprotein
pattern, due to external or host-related factors, may modulate
tissue distribution of carotenoids [169]. At the site of the target
tissue, selective uptake systems may be operative to accumu-
late particular carotenoids, which are further transported to
specific cells of the tissue; or within a cell, directed to sub-
cellular compartments. Uptake might be hindered by tissue
barriers (e.g. the blood–brain barrier), permeable only for cer-
tain compounds, though the lipophilic carotenoids would be
expected to pass. Also, due to their lipophilicity, their vol-
ume of distribution (VD) in the body is quite large [170],
and plasma concentrations will only to some extent reflect
tissue levels. Thus, plasma concentrations are expected to
be influenced if the VD is altered, which may explain lower
circulating carotenoid levels in obese subjects (Table 3). Con-
sequently, this limits measuring plasma carotenoids as the
most suitable marker of body status, and assessing additional
compartments, such as following biopsies, or estimating var-
ious pools following isotopically labelled carotenoids, may
constitute alternatives, though being more invasive or costly
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Table 5. Carotenoid levels in liver and adipose tissue (nmol/g wet weight)
Tissue nmol/g wet tissue (range), or ± SD Reference
-carotene Lycopene Lutein/zeaxanthin
Liver 0.98 1.31 0.29 [172]
(0.21-3.94) (0.16-10.3) (0.10-0.66)
Liver 4.41 5.74 3.22 [173]
(0-19.4) (0-20.7) (0-12.2)
Liver 3.02 1.28 n.m. [175]
(0.16-8.62) (0.1-4.08)
Liver 15.06 25.46 2.94 [174]
(9.1-24.8) (10.2-55.1) (0.2-5.8)
Mean across study 5.9 ± 6.3 8.4 ± 11.5 2.2 ± 1.6
Total carotenoids in livera) (nmol) 9.2 13.2 3.4
Adipose 0.2 0.7 0.79 [172]
(0.05-2.37) (0.02-3.7) (0.29-2.7)
Adipose 0.38 0.2 n.m. [175]
(0-1.05) (0-0.51)
Adipose n.m. 0.23 ± 0.16 n.m. [301]
Adipose 0.37 ± 0.34 0.32 ± 0.35 1.58 ± 0.93 [188]
Mean across study 0.32 ± 0.10 0.36 ± 0.23 1.19 ± 0.56
Total carotenoid in adipose tissueb) 4.4 5.1 16.6
Data shows mean values and range or standard deviation.
n.m.: not measured
a) assuming an average adult liver mass of 1561 g [302]
b) Assuming an average weight of body fat in non-obese adults of 14 kg [303]
[19, 171]. Unfortunately, only little is known about host re-
lated factors such as genetic makeup (e.g. SNPs) or other
individual determinants and their impact on carotenoid tis-
sue distribution.
5.2 Liver
Data from animal and human studies provide evidence that
the hepatic tissue is a major site of carotenoid accumula-
tion andmetabolism [172–175]. -Carotene and lycopene e.g.
are found in the nmol range per gram wet tissue, however,
individual values widely vary (Table 5). Carotenoids travel
with lipoproteins and the liver is a central hub for lipopro-
tein assembling and release. Hepatic endocytosis of chylomi-
cron remnants, which contain newly absorbed carotenoids,
depends on the interaction of the APOE protein with the
membrane receptor LRP1 or to some extent with the LDL-
receptor. Also involved in the uptake mechanism is hepatic
LPL. Carotenoids remain in the liver for storage, alternatively,
they are secreted with VLDLs, which are further processed to
LDLs. Mechanisms involved in the coordination of storage,
cleavage and secretion are however not known yet. It is likely
that the regulation of the specific cleaving enzymes plays a
major role in carotenoid plasma levels.
As noted in earlier publications, tissues such as the liver
(or testes and adrenals) which possess a large number of LDL
receptors, exhibit high levels of carotenoids. On the other
hand, lipids from circulating HDL are taken up by this organ,
too. The central role of the liver in lipid metabolism makes it
likely that individual differences (polymorphisms) in proteins
affecting this process can influence carotenoid distribution.
SNPs in LDL receptors may play a role, as they are critical for
the endocytosis of the remnant chylomicron particle into liver
hepatocytes, influenced by the binding of APOE to the sur-
face of chylomicrons [176], and may therefore be suspected
to play a role in carotenoid distribution. Though carotenoid
levels in plasma have been associated with genetic polymor-
phisms in genes related to lipid metabolism [103], an impact
on tissue distribution or uptake has not been proven so far in
humans. By contrast, mice expressing APOE4 as compared
to APOE3 had lower levels of -carotene in the bloodstream
and lower levels of -carotene and lutein in adipose tissue
[177], while hepatic expression of BCO1/2 was significantly
higher, suggesting a correlation of both factors.
In addition to the conversion of provitamin A carotenoids
into retinal by BCO1, the liver is also a central tissue for
xenobiotic metabolism, mediated by an array of phase I/II
enzymes. Especially the metabolism of carotenoids by cy-
tochromeP450-dependentmonooxygenases has been topic of
research, and an active hepatic P450 dependent metabolism
was shown for several carotenoids [178,179]. Several metabo-
lites have been detected [180] and thus a great deal of P450
related genes expressed in the liver including CYPs 3A4, 2C9,
2C8, 2E1, and 1A2, and to a lesser extent 2A6, 2D6, 2B6,
2C19, plus the extrahepatically expressed CYPs 2J2, 1A1, and
1B1, are expected to potentially influence carotenoid tissue
levels [181]. Phase I and II enzymes are usually inducible
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and respond to internal and external challenges (stress) a
host is exposed to. Thus, in addition to genetic factors, also
external factors can influence the extent of metabolism and
metabolic pattern. A number of different polymorphisms in-
volved in phase I/II enzymes in humans have already been
revealed. They individually affect the metabolism of drugs
or endogenous compounds. Little is known with respect to
carotenoids, but it was shown that a polymorphism regarding
CYP26B1 (rs2241057) influences the degradation of retinoic
acid, and is likely related to the risk of Crohn’s disease [182]
and atherosclerosis [183].
5.3 Adipose tissue
Adipose tissue and in particular the lipid fraction of
adipocytes is an important site of carotenoid accumulation
[172, 184, 185]. Vitamin A is stored in adipose tissue pri-
marily as unesterified retinol [186, 187]. Concentrations of
carotenoids in adipose tissue have been reported by sev-
eral groups [188–190] (Table 5). According to these studies,
concentrations of -carotene, -cryptoxanthin, lycopene and
lutein/zeaxanthin were comparable in variation and concen-
tration to their plasma concentration. Although concentra-
tions of carotenoids per g tissue are higher in some other
organs, adipose tissue contains the highest total amounts,
and is assumed to contribute to carotenoid storage. Unfortu-
nately, knowledge is scarce on the mechanisms involved in
the regulation of carotenoid uptake/release in this tissue.
LPL, expressed in adipose- andother tissues, is the primary
enzyme responsible for triacylglycerol lipolysis, provided by
chylomicron- and VLDL transport vehicles for carotenoids,
and implicated in fatty acid uptake. Thus, it may also play
a role in adipocyte carotenoid uptake. Cell culture studies
suggest that CD36 is involved in the uptake of lycopene and
lutein by adipocytes [88]. Hormone sensitive lipases are im-
plicated in the release of retinol from storage tissue due to
cleavage of retinyl esters, and may aid in releasing retinol by
hydrolyzing triglycerides of the intracellular fat droplets [191].
However, their impact on carotenoid release from adipose
compartments is unclear. Retinol binding protein 4 (RBP4)
is synthesized by adipocytes as a signaling molecule. It was
shown to coordinate bidirectional retinol uptake in adipose
tissue together with its membrane receptor STRA6 (stimu-
lated by retinoic acid gene 6) [192]. Retinol-loaded holo-RBP4
blocked adipocyte differentiation by activating RAR, while
retinol-free apo-RBP4 triggered retinol efflux, resulting in re-
duced cellular retinoids and RAR mediated transcription
and enhanced adipogenesis [192].
Several host related factors have been identified in EU-
RAMIC (European multicenter case-control study on an-
tioxidants, myocardial infarction and breast cancer), scru-
tinizing correlations of carotenoid levels in adipose tis-
sue [193]. In another trial, obesity was associated with
carotenoid levels in adipose tissue, though it is not quite clear
whether this could also be due to decreased dietary intake. A
correlation was also observed between higher alcohol intake
and lower levels of -carotene and lycopene in adipose tissue
of men and women, respectively. Although the concentration
of -carotene in the adipocytes of obese subjects was lower
compared to non-obese, the total amount of -carotene in all
lipid stores was similar [194]. Whether this implies a regula-
tion of total lipid body stores is still controversial. Regarding
alcohol consumption, lower intake, altered liver-metabolism,
decreased small intestinal uptake, or enhanced consumption
due to oxidative stress may play a role. In this context, the ac-
tivity of -carotene metabolizing enzymes is likely important
and genetic differences but also alcohol intake is expected to
affect a balanced distribution in adipose tissues.
Mice in which BCO1 is deleted and receiving marginal
vitamin A sufficient diet with -carotene, accumulate
-carotene in adipose tissue [102]. This illustrates the role
of adipose tissue as a storage tissue for lipophilic compounds
such as carotenoids. Recently, in yellow rabbits, a triplet
deletion was identified in the BCO2 gene, resulting in the
absence of an asparagine in BCO2. This was suggested to
cause accumulation of carotenoids in adipose tissue [195].
This agrees with an earlier finding in sheep, where a BCO2
mutation was found to be tightly associated with white adi-
pose tissue carotenoid accumulation [196], and in bovines
where BCO2 mutations were associated with carotenoid ac-
cumulation in adipose tissue and milk [197, 198]. These ob-
servations were lately confirmed by BCO2 inactivation in
sheep using CRISPR/Cas9 technology, resulting in yellow
fat, establishing a causal relationship between BCO2 activity
and carotenoid accumulation in white adipose tissue [199].
Together, these findings not only illustrate the importance
of white adipose tissue as a carotenoid storage organ, but
also show whole body physiological regulation of carotenoid
homeostasis, posing another layer of complexity on under-
standing inter-individual variation (see also 6.4). This is ex-
emplified by sex specific responses resulting from -carotene
accumulation in white adipose tissue, which showed that
4970 genes were affected in WT female mice, while only
407 were affected in male mice [200], with the majority of
the commonly affected genes (141 out of 144) showing a
strong negative, rather than positive, correlation of expres-
sion between males and females. This negative correlation
was also seen in BCO1 knockout mice, although the number
of genes affected were more similar between the two sexes
(1522 gene in females and 1202 in males, 33 overlapping)
[201]. In both WT and BCO1 knockout mice, only a minor-
ity of genes is commonly affected by -carotene in females
and males. Strikingly, the opposite regulation of genes in
response to -carotene exposure was also prominent in the
lung of BCO1 knockout mice, but this was not seen in WT
mice in this tissue [202]. On the other hand, WT liver showed
a strong positive correlation of -carotene responsive genes
between males and females [201].
Adipose tissue is distributed over various depots in the
body. Functional differences between depots exist and vis-
ceral adipose tissue is especially associated with adverse
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health effects. In a study aiming to identify differences be-
tween adipose tissue depots, it was found that many of the
genes differentially expressed in subcutaneous and visceral
adipose tissue were regulated by retinoic acid [203]. The mas-
ter regulator of adipogenesis, PPARG is functionally active
as an obligatory dimer with RXRA, linking adipogenesis with
vitamin A metabolism. Retinoic acids are generated from
retinaldehyde in adipose tissue by aldehyde dehydrogenase
1 (ALDH1), though this is discussed controversially [187].
Female mice with inactivated ALDH1A1 were resistant to
high-fat diet-induced visceral adipose formation. This was
not seen in male mice, while subcutaneous adipose tissue
was reduced to the same extent in males and females [204].
Together, this underlines a role for vitamin A metabolism in
differential adipose tissue (i.e. visceral versus. subcutaneous)
formation. It has been suggested that estrogenmediated sup-
pression of ALDH1A2/3 mRNA expression is involved in
differential retinoic acid formation between males and fe-
males [205]. Although major gaps in our knowledge exist, ge-
netic variation in uptake, storage and processing in adipose
tissue of various carotenoidsmay influence adipose tissue dis-
tribution and functionality and associated health outcomes,
and, if so, will likely do this in a sex dependent manner.
Effects of carotenoids on adipose tissue biology have been re-
viewed recently [206], while effects of genetic ablation of genes
encoding various retinoid metabolism enzymes, including
BCO1 and ALDH1A1, but also RBP1, RBP3 and retinol sat-
urase (RESTAT) on adiposity inmice are reviewed elsewhere
[203].
5.4 Skin
The carotenoid pattern in human skin comprises carotenes
and xanthophylls. Plasma levels of lycopene and less notably
-carotene are correlated with their respective concentration
in the skin [207]. However, no such correlation was observed
for lutein, zeaxanthin, and -cryptoxanthin, and thus skin
measurements may not be representative of total carotenoid
exposure or status. Carotenoids are not equally distributed in
the different skin areas. Highest levels occur in skin of the
forehead and in the palms of the hands and lower levels in
dorsal skin, inside of the arm or back of hand. LDL-receptors
are expressed in human skin [208] and may play a role re-
garding selective uptake. Skin can be divided into epidermis
and dermis with underlying subcutaneous adipose tissue.
Blood vessels reach the dermis but not the epidermis, and
different ways of how carotenoids may be transported and
distributed to and within the different layers of our skin have
been discussed [209]. Subcutaneous tissue is a storage com-
partment for carotenoids and part of the balanced distribution
system of carotenoids in adipose depots. Thus, host factors
already mentioned above are expected to also play a role in
carotenoid uptake and storage in the skin. There is some
evidence that other host-related factors influence carotenoid
skin levels [210]. On the long term, a carotenoid-rich diet
may increase carotenoid skin levels. However, smoking and
alcohol intake induced a rapid decrease in carotenoid levels of
the skin. Skin lycopene levels are sensitive to UV-irradiation
[211]. Upon irradiation in vivo, lycopene concentration in the
skin is significantly lowered. This effect is less pronounced
with -carotene. Therefore, individual preferences regard-
ing sun or UV exposure (tanning beds) would affect skin
carotenoid concentrations.
5.5 Macula lutea
The macula lutea is a small yellow area of the retina. It is
the region of maximum visual acuity and its yellow color
is due to xanthophylls, mainly lutein, zeaxanthin and meso-
zeaxanathin, located in the cone axons of the Henle fiber
layer. It was shown that macular pigment density was pos-
itively correlated with serum concentrations of lutein and
zeaxanthin, and inversely correlatedwith serumoxidized low-
density lipoprotein [212]. Consequently, host related oxidative
stress conditions would impact the supply of the retina with
oxo-carotenoids. Absolute levels and the patterns of lutein and
zeaxanthin differ within an individual retina sample [213].
Large interindividual differences have also been described
[214]. In the center of the macula lutea, levels of lutein and
zeaxanthin have been reported, with 2.4 and 3.4 pmol/mm²,
respectively. Much lower concentrations are found in periph-
eral areas; medial 0.22 pmol lutein/mm² and 0.14 pmol zeax-
anthin/mm². Levels further decrease in outer circleswhile the
ratio of lutein:zeaxanthin increases. Since carotenes are not
present in the macula lutea, selective mechanisms of uptake
must be operative.
It is likely that host related factors (individual differences)
have an impact on the density of the macula pigment. In a 6
months intervention study with a lutein-rich supplement the
impact of genetic variances in four genes (ABCG8, BCO1,
CD36, and NPC1L1) on lutein plasma levels and macular
pigment optical density was evaluated [215]. The results pro-
vide evidence that (as with plasma) retina levels, i.e. macula
pigment optical density of lutein are affected by SNPs of
CD36 and BCO1. The TT variant at the BCO1 rs7501331
locus was associated with a higher macula pigment optical
density. Study subjects with GG at the CD36 locus rs1761667
had a higher macula pigment optical density compared to
those with an A allele, although the underlying mechanisms
remain to be established. Compounds delivered to the retina
must pass the blood–retinal barrier, provided by tight junc-
tions between endothelial cells. This barrier is sensitive to
inflammatory and oxidative damage often associated with hy-
perglycemia [216]. HDLs as the transport vehicles of lutein
and zeaxanthin have been discussed to play an important
role in the transport of macular carotenoids [217]. There is
evidence that SR-BI, a tissue receptor for HDL, plays a role
in the delivery of carotenoids to this tissue [218].
It was further suggested that the delivery of mac-
ular carotenoids involves the inter-photoreceptor-retinoid
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binding protein. Retinoids and lutein/zeaxanthin have sim-
ilar affinities to this protein, which facilitates the transfer
of lipids across the inter-photoreceptor space [219]. GSTP1
has been identified as the macular binding protein for
zeaxanthin/meso-zeaxanthin in humans [220]. It was shown
that StARD3 acts as the lutein binding protein in the hu-
manmacula [221]. In-vitro studies have proven the selectivity
of both proteins with respect to either zeaxanthin or lutein.
Equilibrium dissociation constants (KD values) for the com-
plex of GSTP1 with zeaxanthin/meso-zeaxanthin are in the
range of 0.14 - 0.19 M while for lutein/-carotene they are
>6-fold higher. Contrarily, StARD3 exhibited a high affinity
to lutein (KD ca. 0.59 M), compared to zeaxanthin/meso-
zeaxanthin (KD-values ca. 1.6 M).
An alternative mechanism contributing to the selective
enrichment of the macula carotenoids in primates has been
suggested [222]. The affinity of the human xanthophyll me-
tabolizing BCO2 for lutein, zeaxanthin, andmeso-zeaxanthin
is 10–40 fold lower than the affinity observed in mice, who
do not accumulate these carotenoids in the retina. Thus, it
has been speculated that ineffective cleavage of xanthophylls
contributes to their accumulation in the macula lutea. BCO2
knockout mice, unlike WT mice, accumulate zeaxanthin in
their retinas. Thus, genetic variances in the respective en-
zymes or transport proteins likely affect the accumulation,
distribution, and metabolism of oxo-carotenoids in the mac-
ula lutea.
5.6 Tissues relevant for cardiovascular diseases
Besides the adipose tissue, other tissues such as the pancreas
and various cells of the vascular system, including endothe-
lial cells and macrophages, are important targets of related
health beneficial effects of carotenoids. In an older study,
carotenoid levels in the pancreas were found to be compa-
rable (1.8-4.5 g/g wet weight [223] or 4.5-95 g/g [224]) to
those in adipose tissue levels. The beneficial and risk pre-
ventive effects of carotenoids on atherosclerosis development
were suggested to be mediated in macrophages and the en-
dothelial cells of the blood vessels [225, 226]. Unfortunately,
a direct mechanistic connection of carotenoid levels in white
blood cells and especially monocytes/macrophages, as well
as endothelial cells and further induced biological effects was
never examined and confirmed.
As carotenoids were described in relation to the preven-
tion of T2D, a potential target organ is the pancreas as a
major regulator for insulin and glucagon production and se-
cretion. Recently, RAR- and RXR-mediated signaling path-
ways were positively and negatively correlated with insulin
and glucagon secretion [227], respectively. As pro-vitamin A
carotenoids are the major precursor for the physiological and
nutritional ligands of these two receptor subclasses [228], a
further genetic regulation related to carotenoids appears plau-
sible, but has not yet fully confirmed and described. This plau-
sible correlation to T2D, starting from beneficial regulatory
pathways of retinoids as carotenoid metabolites via RAR- and
RXR-mediated signaling pathways seems also to be highly de-
pendent on carotenoid accumulation for substrate availability
[229].
5.7 Other tissues
Carotenoids occur in almost all human tissues. However,
some were in the focus of research. Based on epidemiological
studies, it was proposed that a frequent intake of tomato prod-
ucts rich in lycopene is associated with a decreased risk for
prostate cancer [230], though it is unclear whether lycopene
is selectively taken up in the prostate and which mechanisms
may be relevant in this context. Levels of lycopene in prostate
tissue have been reported around 1.7 ng/mg tissue following
supplementation [231]; similar to levels in adipose and liver
(Table 5).
In the human brain carotenes and xanthophylls were
detected and the latter accounted for about 70% of total
carotenoids, with lutein and zeaxanthin dominating [232].
Levels were different in different brain areas and ranged from
2.8 to 11.8 pmol/g for lutein, 1.8 to 9.2 pmol/g zeaxanthin,
and 7.6 to 15.2 pmol/g -carotene. A supplementation study
with rhesusmonkeys has shown that the brain levels of lutein
and zeaxanthin are significantly related to their levels in the
macula lutea [233], and therefore, macular pigment density
may be used as a surrogate biomarker of lutein and zeaxan-
thin in primate brain tissue. Analyses of human brain tissues
revealed a relationship between StARD3 levels and the con-
centration of lutein [234], with strongest correlations observed
in infant (versus. adult or centenarian) brains.
Colostrum contains significant amounts of - and -
carotene, lycopene, -cryptoxanthin, canthaxanthin, lutein
and zeaxanthin, which are responsible for the yellow color.
With ongoing lactation the content of carotenoids in ma-
ture milk declines, and the carotenoid pattern changes [235],
being correlated with lower lipid content of breast milk
[236]. This could suggest that a temporal specific mechanism
is involved in the transfer of carotenoids to human milk,
though via whichmechanism is not understood. On the other
hand, breast adipose tissue carotenoid concentrations from
tumor patients were significantly related to serum concentra-
tions, and were highest for -cryptoxanthin (3.5 mol/kg),
-carotene (2.3 mol/kg) and lutein (1.8 mol/kg), not indi-
cating a considerable change of patterns [237].
Kidney concentrations, as other organ carotenoid levels,
appear more variable than plasma concentrations, and have
been reported to be in the range of 0.2–12.7 nmol/g for to-
tal carotenoids [173]. However, a significant correlation for
total carotenoids was found between liver, kidney and lung,
thus additional discriminations of patterns could not be con-
cluded. Again, host related factors especially those regarding
the genetic variations of the proteins mention above might
have impact on carotenoid distribution in these tissues.
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6 Host factors interacting with carotenoid
storage and excretion pathways
6.1 Storage and turnover aspects
Very little is known on the metabolism of especially non-
provitamin A carotenoids in xenobiotic pathways and on the
extent of degradation and elimination of the parent com-
pounds [238]. Lutein and -carotene may interact with each
other during postprandial serum clearance when adminis-
tered together. Both mutually enhancing and inhibiting ac-
tions have been observed in the limited number of volun-
teers studied. Interindividual differences in the response
were studied after a high dose (0.5 mol/kg body weight)
of either or both carotenoids followed by blood sampling
[159, 239]. On average, the volunteers showed faster post-
prandial serum elimination (up to 120 h) of both carotenoids
when given together, while subsequent elimination (up to 32
days) was unaffected by the other carotenoid. In line with this
trial, the loss of liver vitamin A in rats dosed with -carotene
was not affected by concomitant dosing with lutein; however,
the initial storage was enhanced by smaller lutein doses and
inhibited by larger doses [240]. Effects during -carotene ab-
sorption appear more likely to explain the inhibitory actions
of lutein, whereas the enhanced vitamin A storage following
-carotene dosing by low concomitant doses of lutein is more
difficult to explain, and may involve interactions other than
at the step of absorption. However, it is apparent from this
study that (at least in rats) lutein does not affect subsequent
loss of hepatic or renal stores of vitamin A. Whether a simi-
lar phenomenon on initial retinol storage exists in humans,
which could partially explain interindividual variation in body
stores of carotenoids is not known.
Carotenoid kinetic aspects were determined in depletion
studies of 70–80 days in females (18–42 years) with and
without isotope dilution by Burri et al. [241]. Following a
carotenoid controlled diet, carotenoids were measured in
blood plasma of 19 healthy adults, and half-lives recorded.
Lutein had the longest half-life (76 ± 17 days), followed by
-carotene, -cryptoxanthin, zeaxanthin, -carotene and ly-
copene (45 ± 7, 40 ± 5, 38 ± 7, 37 ± 5, and 27 ± 3 days,
respectively), with lutein and lycopene differing significantly
in half-lives from other carotenoids. Other studies based on
postprandial designs have reported other half-lives, such as
2–3 days for lycopene and 5–7 days for -carotene [242],
likely to reflect plasma exchange with deeper compartments,
while the longer reported half-lives would reflect losses from
those deeper compartments. In the study by Burri et al., all
carotenoids followed similar first order kinetic rates, indicat-
ing a small variation in plasma kinetics but clear differences
in carotenoid half-lives. Concentrations of all carotenoids
were highly correlated. The differences in carotenoid half-
lives were unexplained, though differences in degradation by
acting as antioxidants or transfer to deeper compartments
were suspected. Half-lives were unrelated to physical or
demographic characteristics (BMI, energy metabolism,
cholesterol and triglyceride levels, ethnicity, or age). How-
ever, the number of subjects was small and participants in
this study rather homogenous. Thus, it is difficult to judge
the effect of half-lives on interindividual carotenoid variations
regarding blood levels.
In a study by Shvetsov et al. [243], the shorter half-
life of lycopene was considered as an explanation for the
higher intraindividual variability of plasma lycopene com-
pared to other carotenoids (lutein, -carotene). In their study,
plasma carotenoids of 381 women were measured repeat-
edly (4 times) with 4 month intervals, and intraindividual
variability was approximately half of that of interindividual
variability, except for lycopene, where it was equal. Similar
higher intraindividual variability for lycopene was also found
by Cooney et al. [244]. The source of intra-individual variation
is unclear. Seasonal variations appeared to be low (below 3%
in the study by Shvetsov, partly due to the constant climate
of Hawaii). When adjusted for age, race, alcohol drinking,
and tobacco smoking, intraclass correlation coefficients were
0.69, 0.45, and 0.74 for total plasma lutein, lycopene, and
-carotene, respectively. Dietary factors, age, gender, ethnic-
ity, geographic location, and season were employed as main
factors to explain intraindividual variability. A slightly better
correlation with increased age was also reported, for reasons
unknown. Further studies need to investigate the potential
effect of diet, life-style and additional factors on carotenoid
depletion rates.
Not much is known regarding carotenoid excretion path-
ways. Khachick et al. reported on polar metabolites of ly-
copene in humans [179], approximately 5% of an isotopically
labelled -carotene (14C) dose was excreted in urine (70% in
feces) during 12 d [245]. The minor fraction excreted in urine
likely represents polar metabolites. In rat hepatocytes, it was
shown that astaxanthin could be metabolized into 3-hydroxy-
4-oxo--ionol, 3-hydroxy-4-oxo--ionone, and their reduced
forms, 3-hydroxy-4-oxo-7,8-dihydro--ionol and 3-hydroxy-4-
oxo-7,8-dihydro--ionone, and that this was associated with
induction of the cytochrome P450 enzyme (CYP3A4 as well
as of CYP2B6) [180]. Thus, alterations in P450 enzyme ac-
tivity may influence carotenoid metabolism. In human ker-
atinocyte cells, it was shown that various CYP enzymes me-
tabolized all-trans retinoic acid and cis-isomers into water
soluble products [246].
6.2 Disease conditions altering carotenoid turnover
Several clinical conditions related to carotenoid status affect
carotenoid concentrations in human plasma, in addition to
those involved in hampering carotenoid uptake (see chap-
ter 3.4). However, it is often difficult to assess whether this
happens by interference with carotenoid uptake, excretion
and/or metabolism. In patients with renal failure, plasma
-carotene levels increased [247]. In the same study,
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decreased plasma levels of -carotene were observed in
subjects with liver cirrhosis. Similarly, a study measuring
carotenoids in tissues by needle biopsies showedmuch lower
hepatic levels at all stages of liver disease [248]. Another study
examined -carotene plasma concentration in 53 Filipino
children with cholestatic liver disease and found decreased
concentrations in 45 patients [249]. This suggests that liver
diseases interfere with storage and excretion of carotenoids.
In the same study, six children received a single dose of 10
mg/kg body weight of -carotene. No increased plasma lev-
els were detectable in 5/6 children, pointing to a main effect
of the disease on -carotene absorption rather than further
metabolism (re-distribution or excretion). This was explained
by missing bile salt secretion and reduced solubilisation and
cellular uptake. However, infections (e.g. helminths) could
not be excluded as an additional factor.
The liver, via the bile, also plays an important part in the
excretion of carotenoids back into the gut. As many trans-
porters expressed in the intestine are also present in liver
cells [250], it can be assumed that genetic differences in e.g.
SCARB1 and CD36 do also influence biliary excretion, how-
ever, this constitutes a gap in our knowledge. In a study
with the purpose of comparing plasma and biliary concentra-
tions of carotenoids among controls and patients with biliary
and pancreatic diseases, both plasma and bile concentrations
of -carotene were significantly decreased in patients with
bile duct stones, impairing biliary excretion. Moreover, the
plasma/bile ratio was maintained as well as the correlation
between them, and plasma -carotene decreased even more
in patients with complete biliary obstruction, probably re-
flecting malabsorption due to limited carotenoid solubilisa-
tion in the gut. A tight correlation between plasma and bile
-carotene still persisted in patients with pancreatic disease,
confirming the role of plasma -carotene in determining bile
concentrations [251]. The authors concluded that carotenoids
undergo, at least in part, biliary excretion, that biliary concen-
trations reflect plasma levels in both normal and pathologic
states, and that a decreased biliary excretion does not increase
plasma concentrations. The study thus mainly highlights the
importance of the bile for carotenoid absorption and the con-
sequent tight link between bile and plasma levels.
Obesity was associated with circulating plasma
carotenoids in several studies (Table 1), however, the
amount of carotenoids in the total adipose tissue has been
found constant among obese and normal-weight subjects
[194]. It is possible that a higher amount of adipose tissue
with its high affinity to store carotenoids merely reduces
the release of carotenoids into the bloodstream or enhances
their uptake from the circulatory system, possibly via LDL
receptors. As obesity is related to chronic inflammation,
it cannot be excluded that upregulation of nuclear factor
kappa-B (NF-B) and nuclear factor erythroid-derived 2 like
2 (NRF2) [252] is somehow related to a higher degradation
rate of carotenoids, but this remains hypothetical. On
the other hand, it is possible that the body may adapt to
increased oxidative stress by upregulating circulating plasma
antioxidants. For example, in a study with asthmatic women,
higher levels of total carotenoids were found compared to
non-asthmatic control women [253].
An enhanced conversion of -carotene to retinol was sug-
gested to explain significantly lower (by approximately 50%)
serum levels of-carotene in hyperthyroid patients compared
to those with hypo- and euthyroidism [254]. However, the de-
tailed mechanism remains unclear. Hypothyroidism also led
to increased (2-fold) -carotene absorption in this study, ex-
plaining the yellowing of the skin in these patients. Thyroid
hormones may thus alter -carotene absorption, however an
effect on its distribution cannot be ruled out.
6.3 Effect of vitamin A status and lifestyle on
carotenoid status
It has been demonstrated that vitamin A status modulates
-carotene absorption and cleavage (see chapter 3.2). A study
examined the ability of deuterated retinol-dilution to detect
changes in the body pool size and status of vitamin A and the
effect on the bioconversion of carotenoids to vitamin A [255].
Changes were detected in the body pool size after 3 days. The
bioconversion of dietary mixed plant food carotenoids varied
inversely with vitamin A status, and improvements in status
after interventionwere strongly affected by total body stores of
vitamin A, which can be explained by feed-back mechanism
of vitamin A status and BCO1, highlighting the relation of
circulating pro-vitamin A carotenoids and vitamin A status.
Chronic alcohol consumption may perturb vitamin A and
carotenoid metabolism. A study in rats given vitamin A or
-carotene examined the effect of chronic alcohol consump-
tion on vitamin A status and found a decrease in hepatic vita-
min A storage, which was not due to malabsorption of either
retinyl acetate or -carotene, nor to altered activities of several
enzymes involved in ethanol or vitamin A metabolism [256].
However, other studies show inconsistent findings; studies
suggested inhibition of BCO1/2 by ethanol [257].
6.4 BCO1/2 aspects with respect to carotenoid
tissue levels
As for the intestine, disruption of BCO1 expression is well
known to reduce vitamin A and increase -carotene concen-
tration in tissues, identifying BCO1 as the major enzyme
for vitamin A production and for carotenoid cleavage [258].
The role of carotenoid oxygenases involved in the cleavage
and storage of carotenoids is confirmed by other studies.
For example, expression of BCO1 was documented by RNA
blotting and immunostaining methods in a wide selection
of human tissues [126, 259]. In the study by Lindquist et al.
in mice, BCO1 was expressed in virtually all tissues, and
the same is assumed for humans. An animal study exam-
ined the effect of knockout BCO1/2 in mice given a con-
trolled diet primarily providing -carotene [39]. Accumulated
levels of -carotene in serum, liver and lungs in BCO1(−/−)
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and BCO1(−/−)/BCO2 (−/−) mice were found. BCO1(−/−) mice
showed 100 fold higher concentrations of -carotene in tis-
sues compared to wildtype and BCO2(−/−) mice, confirming
the role of BCO1 as the major -carotene-metabolizing en-
zyme. This does not negate a role for BCO2, since BCO2
inactivation in sheep resulted in carotenoid accumulation in
adipose tissue [199].
Another study in mice investigated the effect of gene ex-
pression induced by -carotene supplementation, knockout
of BCO1, and differences in gender on -carotene levels in
lungs, liver and inguinal white adipose tissue [200]. Lungs
were mainly affected by knockout, liver by knockout and gen-
der, while the white adipose tissue was mainly affected by
gender. Hardly any -carotene affected genes were in com-
mon in the three tissues, suggesting that changes in gene
expression are primarily determined by tissue and gender.
-Carotene exposure increases -carotene concentration
in the lung, but also the concentrations of retinol and retinyl
esters [260]. Inactivation of BCO1 increases -carotene con-
centrations, and decreases retinyl ester concentrations in
males and females, while retinol concentration are only de-
creased in females [261]. Differential regulation of genes in-
volved in vitamin A metabolism in the lung upon -carotene
exposure, for example LRAT (conversion of retinol in retinyl
esters) and ADH7 (conversion of retinol into retinal) suggest
that polymorphisms in these genes can also have a role in
interindividual responses, which could be relevant because
these genes can functionally determine retinoid sufficiency
[260].
7 Bioactivation - from carotenoids to
nuclear hormone receptor ligands and
further induced transcriptional
signaling
The mechanisms of action of carotenoids regarding benefi-
cial health effects comprises twomajor pathways: a) function-
ing as direct antioxidants via various pathways [262], which
has recently been discussed controversially due of lack of
sufficiently high concentrations to transmit these effects en-
dogenously [252] and b) functioning as precursors of various
oxidative cleavage products [263]. These can further interact
with various nuclear hormone receptors such as the RAR,
RXR, PPARs, LXRs, FXR, NF-B, and NRF2 [252, 264]. This
conversion was mainly demonstrated in cellular and mouse
studies, while in humans merely individual steps of this acti-
vation cascade were confirmed [97, 98, 229, 265, 266].
Assuming that that carotenoids function mainly via pre-
cursors of nuclear hormone receptors implies that not the
serum and organ levels of native carotenoids are of ma-
jor importance, but mainly the conversion of these en-
dogenous present carotenoids to oxidative cleavage products.
This again highlights the importance of the two carotenoid
oxygenases BCO1/2. When focussing on health related ef-
fects of carotenoids, the focus should be placed on correlat-
ing carotenoid intake with resulting endogenous carotenoid
metabolite levels and their effects on nuclear hormone
receptor mediated signaling, not merely on the concentra-
tions of the native carotenoids, however, data on these are still
scant. In this regard, the retinoic acid receptors (RARs), with
the isotypes RAR,  and , are activated mainly by the provi-
tamin A carotenoid metabolite all-trans-apo-15´-carotenoic
acid (all-trans retinoic acid [267]). In addition, non-well ex-
amined pathways with low affinity activation ligands such
as all-trans-4-oxo-retinoic acid [268], all-trans-3,4-didehydro
retinoic acid [269] and all-trans-13,14-dihydroretinoic acid ac-
tivation were described [270]. The activation of the RAR as
well as the RXR (RXR,  and ) by 9CRA seems to be of
non-physiological relevance, due to low or even non-existing
transcriptional activation of both RARs and RXRs by relevant
endogenous levels [118, 119].
Recently, in addition to -carotene functioning as the
major precursors for nuclear hormone receptor ligands for
RARs and RXRs, the acyclic carotenoid lycopene was de-
scribed to transmit further RAR-mediated signaling [97,271].
Alternatively, RXR- and PPAR-mediated signaling was pos-
tulated to be mediated via lycopene oxidative metabolites.
The detailed mechanisms including the actively involved ly-
copene oxidative metabolites remains still controversial but
it is likely involving apo-15´-lycopenoids for further RXR-
mediated signaling [97] and apo-10´-lycopenoids for further
PPAR-mediated signaling [98]. Future research should focus
on correlating carotenoid intake with carotenoid levels in the
individual, furthermetabolic conversion to bioactive oxidative
carotenoid metabolites, and the identification and quantifica-
tion of marker genes related to beneficial health effects.
8 Conclusion and perspective
Interindividual carotenoid variability following intervention
studies with dietary carotenoids has been investigated in a
number of body compartments, including digesta, chylomi-
crons, blood, skin, and the retina. Additional variation has
been observed in observational studies (Fig. 2). Variability in
the carotenoid bioaccessible fraction is approximately half of
that of plasma concentrations, approximately 20–30%. This
may indicate that about half the variability may be explained
by factors influencing carotenoid bioaccessibility, namely di-
gestion enzyme concentrations, bile salts, and intestinal tran-
sit time. These are influenced by diseases (e.g. short bowel
syndrome), the microbiota, and also gene expression re-
lated to enzymes (gastric lipase, PNLIP, CEL, CLPS). Factors
influencing absorption also include parasites, such as hook-
worms, i.e. factors decreasing absorptive surface. Carotenoid
absorption itself may be influenced by uptake transporters
and associated SNPs (e.g. in theCD36,NPC1L1, andSCARB1
genes). Intracellular transport and chylomicron or also HDL
secretion (ABCA1) have been associated with ABCG5/8,
FABP2, ELOVL2, INSIG2, SLC27A6, and MTP, and intra-
cellular cleavage with BCO1, likely involving BCO2 for some
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Figure 2. Overview of factors
likely to contribute to interindi-
vidual variation of carotenoid
bioavailability and thus tissue
concentrations.
carotenoids. Further biodistribution, affecting plasma levels,
likely include LPL, LIPC, CETP, and APOA1, APOA4, APOE
andAPOB.Tissue incorporation is influencedby all these pre-
ceding processes, in addition to specific uptake transporters
such as GSTP1, StARD3, and RPE65, in case of the retina.
Many other SNPs, involved in inflammatory processes and
certain diseases have been shown to correlate with carotenoid
tissue levels (Table 4), though their exact role and contribution
to variability remains to be elucidated. Hormones and gender
play a role, as do possibly age andpercentage of adipose tissue,
though again the mechanisms are not comprehended. Sev-
eral diseases have also been reported to influence carotenoid
turnover and excretion, including hyperthyroidism and dis-
eases of the liver and kidney, though the underlying mecha-
nisms are not understood. While thus many of the potential
candidates explaining interindividual variability, especially
concerning cellular uptake and cleavage in the epithelium,
have been determined, much less is known on their actual
contribution to interindividual variability, and less is known
on factors effecting intraindividual variability, which appears
to be approximately half of interindividual variability accord-
ing to some studies (Table 3). Influences of season and diet
are most likely to contribute. In addition, we tried to empha-
size connections between the individual carotenoid levels in
the organisms and their bioactivation, resulting in oxidative
carotenoid cleavage metabolites, mainly retinoids, and fur-
ther mediation of transcriptional signaling of health related
marker genes.
In the future, studies should aim at identifying additional
SNPs related to carotenoid ADME parameters, to increase
our knowledge on the contribution of genetic variations to
interindividual variability. This may include SNPs in genes
encoding for digestion enzymes and proteins involved in fur-
ther tissue distribution, which so far have received limited
attention. Furthermore, the connection between SNPs and
health relatedmarker genes should be in the focus of research
to scrutinize carotenoid health protective effects. In addition,
epigenetic factors and the microbiota are areas which until
to date have been mostly overlooked. These will reveal new
insights into explaining the variability of carotenoid concen-
trations in human tissues, but perhaps also explain varying
biological responses to dietary intervention, opening the door
to personalized nutrition and “food to health” strategies em-
ploying carotenoids.
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